新版　卵巣組織凍結・移植　新しい妊孕性温存療法の実践

出版社： 医歯薬出版
著者：
発行日： 2021-08-20
分野： 臨床医学：外科  >  産婦人科学
ISBN： 9784263732021
電子書籍版： 2021-08-20 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

16,500 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,500 円(税込)

購入する

商品紹介

小児・AYA（思春期・若年）世代の女性がん患者の妊孕性温存療法として、今後の普及・発展がおおいに期待されている卵巣組織凍結・移植。
本技術をあらゆる角度から検討しまとめた、本邦唯一かつ世界でも希有の書。
卵巣組織凍結保存を実施している施設は2013年4月時点の7施設から、2020年10月現在で48施設と全国に幅広く拡大中。
さらに、小児・AYA世代がん患者等への卵巣組織凍結については、2021年4月より国の公的助成金制度が開始されている。

目次


  • 第1章　卵巣組織の凍結の基礎
    　01　卵巣組織凍結の歴史
    　02　卵巣組織凍結の現状（海外ならびに日本におけるガイドラインを含めて）
    　03A　卵巣組織凍結・移植の現状（乳がん）
    　03B　卵巣組織凍結・移植の現状（ターナー症候群，造血器腫瘍ほか）
    　04　凍結生物学Cryobiology（基礎）
    　05　凍結生物学Cryobiology（臨床）
    　06　卵巣組織の“緩慢凍結法”
    　07　卵巣組織の“超急速凍結法”
    　08　卵巣組織のガラス化保存法～Type M（R）とOva Cryo Closed Device（R）について
    　09　卵巣組織のガラス化保存法：Cryotissue（R） Kit
    　10　卵巣組織凍結に関するその他の話題
    　11　卵巣組織凍結法（緩慢凍結法 vs. ガラス化法）

    第2章　卵巣組織の採取と移植
    　12　卵巣組織凍結における患者説明
    　13　卵巣組織採取の実際～Reduced port surgeryによる卵巣摘出手術～
    　14　小児・思春期患者に対する卵巣組織凍結保存
    　15　卵巣組織移植の最新知見
    　16　卵巣組織移植の実際～残存卵巣への同所性移植について～

    第3章　卵巣組織の凍結・移植に関する諸問題
    　17　化学療法，放射線療法による卵巣毒性
    　18　がん細胞の再移入に関して

    第4章　卵巣組織の凍結の将来
    　19　卵巣輸送
    　20　原始卵胞の体外発育-体外成熟
    　21　卵子幹細胞
    　22　人工卵巣
    　23　精巣組織凍結

    第5章　本邦におけるがん・生殖医療への支援
    　24　第3期がん対策推進基本計画とわが国におけるAYAがん医療の充実
    　25　がん・生殖医療連携
    　26　がん・生殖医療における妊孕性温存療法に対する公的助成金制度
    　27　法的側面からみたがん・生殖医療
    　28　卵巣組織凍結における長期保管体制

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 卵巣組織の凍結の基礎

P.6 掲載の参考文献
1. Suzuki N, Yoshioka N, Takae S, et al.:Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30:608-615.
PubMed
2. 日本産科婦人科学会:医学的適応による未受精卵子, 胚(受精卵)および卵巣組織の凍結・保存に関する見解 2019年改訂. http://www.jsog.or.jp/modules/statement/index.php?content_id=23
 
3. 日本産科婦人科学会:施設検索. http://www.jsog.or.jp/facility_program/search_facility.php
 
4. Smith AU, Parkes AS:Preservation of ovarian tissue at low temperatures. Lancet. 1951;2:570-572.
PubMed
5. Parkes AS, Smith AU:Regeneration of rat ovarian tissue grafted after exposure to low temperatures. Proc R Soc Lond B Biol Sci. 1953;140:455-470.
PubMed
6. Parkes AS, Smith AU:Preservation of ovarian tissue at -79 degrees C. for transplantation. Acta Endocrinol(Copenh). 1954;17:313-320.
PubMed
7. Deanesly R:Immature rat ovaries grafted after freezing and thawing. J Endocrinol. 1954;11:197-200.
PubMed
8. Deanesly R:Egg survival in immature rat ovaries grafted after freezing and thawing. Proc R Soc Lond B Biol Sci. 1957;147:412-421.
PubMed
9. Parkes AS:Viability of ovarian tissue after freezing. Proc R Soc Lond B Biol Sci. 1957;147:520-528.
PubMed
10. Parrott DMV:The fertility of mice with orthotopic ovarian grafts derived from frozen tissue. J Reprod Fertil. 1960;1:230-241.
 
11. Chihal HJ, Stone SC, Peppler RD:The effect of frozen ovarian autografts on compensatory ovulation and steroid production in unilaterally ovariectomized rats. Am J Anat. 1976;145:433-441.
PubMed
12. Daniel JCJ, June SC:Cryopreservation of sliced bovine ovaries. Theriogenology. 1987;27:220.
 
13. 利部 聰, 牧田 登, 萬場 光ほか:凍結・融解したラット卵巣の卵巣嚢内への移植. 哺乳卵研誌. 1988;5:89-97.
 
14. Gosden RG, Baird DT, Wade JC, et al.:Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod. 1994;9:597-603.
PubMed
15. Shaw JM, Bowles J, Koopman P, et al.:Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996;11:1668-1673.
PubMed
16. Gunasena KT, Villines PM, Critser ES, et al.:Live births after autologous transplant of cryopreserved mouse ovaries. Hum Reprod. 1997;12:101-106.
PubMed
17. Donnez J, Bassil S:Indications for cryopreservation of ovarian tissue. Hum Reprod Update. 1998;4:248-259.
PubMed
18. Oktay K, Newton H, Aubard Y, et al.:Cryopreservation of immature human oocytes and ovarian tissue:an emerging technology? Fertil Steril. 1998;69:1-7.
PubMed
19. Meirow D, Ben Yehuda D, Prus D, et al.:Ovarian tissue banking in patients with Hodgkin's disease:is it safe? Fertil Steril. 1998;69:996-998.
PubMed
20. Gook DA, McCully BA, Edgar DH, et al.:Development of antral follicles in human cryopreserved ovarian tissue following xenografting. Hum Reprod. 2001;16:417-422.
PubMed
21. Lee DM, Yeoman RR, Battaglia DE, et al.:Live birth after ovarian tissue transplant. Nature. 2004;428:137-138.
PubMed
22. Oktay K, Economos K, Kan M, et al.:Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001;286:1490-1493.
 
23. Oktay K, Buyuk E, Veeck L, et al.:Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;363:837-840.
PubMed
24. Donnez J, Silber S, Andersen CY, et al.:Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med. 2011;43:437-450.
 
25. Callejo J, Salvador C, Gonzalez-Nunez S, et al.:Live birth in a woman without ovaries after autograft of frozen-thawed ovarian tissue combined with growth factors. J Ovarian Res. 2013;6:33.
 
26. Soleimani R, Heytens E, Oktay K:Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. PLoS One. 2011;6:e19475.
PubMed
27. Kagawa N, Silber S, Kuwayama M:Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online. 2009;18:568-577.
PubMed
28. Hashimoto S, Suzuki N, Yamanaka M, et al.:Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues. Reprod Biomed Online. 2010;21:501-509.
PubMed
29. Igarashi S, Suzuki N, Hashimoto S, et al.:Heterotopic autotransplantation of ovarian cortex in cynomolgus monkeys. Hum Cell. 2010;23:26-34.
PubMed
30. Amorim CA, Curaba M, Van Langendonckt A, et al.:Vitrification as an alternative means of cryopreserving ovarian tissue. Reprod Biomed Online. 2011;23:160-186.
PubMed
31. Nottola SA, Camboni A, Van Langendonckt A, et al.:Cryopreservation and xenotransplantation of human ovarian tissue:an ultrastructural study. Fertil Steril. 2008;90:23-32.
PubMed
32. Ting AY, Yeoman RR, Lawson MS, et al.:In vitro development of secondary follicles from cryopreserved rhesus macaque ovarian tissue after slow-rate freeze or vitrification. Hum Reprod. 2011;26:2461-2472.
PubMed
33. Amorim CA, Jacobs S, Devireddy RV, et al.:Successful vitrification and autografting of baboon(Papio anubis)ovarian tissue. Hum Reprod. 2013;28:2146-2156.
PubMed
34. Donnez J, Dolmans MM, Pellicer A, et al.:Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue:a review of 60 cases of reimplantation. Fertil Steril. 2013;99:1503-1513.
 
35. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
36. Andersen CY, Rosendahl M, Byskov AG, et al.:Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23:2266-2272.
PubMed
37. Ernst E, Bergholdt S, Jorgensen JS, et al.:The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod. 2010;25:1280-1281.
PubMed
38. ESHRE Working Group on Oocyte Cryopreservation in Europe;Shenfield F, de Mouzon J, Scaravelli G, et al.:Oocyte and ovarian tissue cryopreservation in European countries:statutory background, practice, storage and use. Hum Reprod Open. 2017;2017:hox003.
 
39. Dolmans M, Jadoul P, Gilliaux S, et al.:A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013;30:305-314.
PubMed
40. Takae S, Suzuki N:Current state and future possibilities of ovarian tissue transplantation. Reprod Med Biol. 2019;18:217-224.
PubMed
41. Fisch B, Abir R:Female fertility preservation:past, present and future. Reproduction. 2018;156:F11-F27.
PubMed
42. Dittrich R, Hackl J, Lotz, et al.:Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103:462-468.
 
43. Imbert R, Moffa F, Tsepelidis S, et al.:Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility:a 12-year retrospective analysis. Hum Reprod. 2014;29:1931-1940.
PubMed
44. Jensen A, Kristensen S, Macklon K, et al.:Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark. Hum Reprod. 2015;30:2838-2845.
PubMed
45. Rosendahl M, Schmidt K, Ernst E, et al.:Cryopreservation of ovarian tissue for a decade in Denmark:a view of the technique. Reprod Biomed Online. 2011;22:162-171.
 
46. Hoekman E, Louwe L, Rooijers M, et al.:Ovarian tissue cryopreservation:Low usage rates and high live-birth rate after transplantation. Acta Obstet Gynecol Scand. 2020;99:213-221.
PubMed
47. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
48. 鈴木 直, 吉岡伸人, 杉下陽堂ほか:がん・生殖医療の実践に基づいた化学療法後の妊孕性温存の可能性について. 癌と化学療法. 2012;39:151-157.
Medical*Online
P.15 掲載の参考文献
1. Anderson RA, Baird DT:The development of ovarian tissue cryopreservation in Edinburgh:Translation from a rodent model through validation in a large mammal and then into clinical practice. Acta Obstet Gynecol Scand. 2019;98:545-549.
 
2. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
3. Practice Committee of the American Society for Reproductive Medicine:Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy:a committee opinion. Fertil Steril. 2019;112:1022-1033.
 
4. ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, et al.:ESHRE guideline:female fertility preservation. Hum Reprod Open. 2020 Nov 14;2020(4):hoaa052.
 
5. Shi Q, Xie Y, Wang Y, Li S:Vitrification versus slow freezing for human ovarian tissue cryopreservation:a systematic review and meta-anlaysis. Sci Rep. 2017;7:8538.
 
6. Roness H, Meirow D:FERTILITY PRESERVATION:Follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158:F35-F44.
PubMed
7. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
8. Stern CJ, Gook D, Hale LG, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod 2013;28:2996-2999.
 
9. Hossay C, Donnez J, Dolmans MM:Whole Ovary Cryopreservation and Transplantation:A Systematic Review of Challenges and Research Developments in Animal Experiments and Humans. J Clin Med. 2020;9:3196.
PubMed
10. Oktay K, Taylan E, Kawahara T, et al.:Robot-assisted orthotopic and heterotopic ovarian tissue transplantation techniques:surgical advances since our first success in 2000. Fertil Steril. 2019;111:604-606.
PubMed
11. Anderson RA, Wallace WH, Baird DT:Ovarian cryopreservation for fertility preservation:indications and outcomes. Reproduction. 2008;136:681-689.
PubMed
12. Wallace WH, Smith AG, Kelsey TW, et al.:Fertility preservation for girls and young women with cancer:population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15:1129-1136.
 
13. Poirot C, Brugieres L, Yakouben K, et al.:Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center. Acta Obstet Gynecol Scand. 2019;98:630-637.
 
14. Klipstein S, Fallat ME, Savelli S;COMMITTEE ON BIOETHICS;SECTION ON HEMATOLOGY/ONCOLOGY;SECTION ON SURGERY. Fertility Preservation for Pediatric and Adolescent Patients with Cancer:Medical and Ethical Considerations. Pediatrics. 2020;145:e20193994.
PubMed
15. Nahata L, Woodruff TK, Quinn GP, et al.:Ovarian tissue cryopreservation as standard of care:what does this mean for pediatric populations? J Assist Reprod Genet. 2020;37:1323-1326.
PubMed
16. Suzuki N, Yoshioka N, Takae S, et al,:Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod, 2015;30:608-615.
PubMed
17. Yding Andersen C, Mamsen LS, Kristensen SG. FERTILITY PRESERVATION:Freezing of ovarian tissue and clinical opportunities. Reproduction. 2019;158:F27-F34.
PubMed
18. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies:an Ethics Committee opinion. Fertil Steril. 2018;110:380-386.
PubMed
19. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
20. ISFP Practice Committee, Kim SS, Donnez J, Barri P, et al.:Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet. 2012;29:465-468.
PubMed
21. Schuring AN, Fehm T, Behringer K, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I:Indications for fertility preservation. Arch Gynecol Obstet. 2018;297:241-255.
PubMed
22. von Wolff M, Germeyer A, Liebenthron J, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. PartII:fertility preservation techniques. Arch Gynecol Obstet. 2018;297:257-267.
 
23. 日本癌治療学会編:小児, 思春期, 若年がん患者における妊孕性温存に関するガイドライン2017年版. 金原出版, 2017.
 
24. Shapira M, Dolmans MM, Silber S, et al.:Evaluation of ovarian tissue transplantation:results from three clinical centers. Fertil Steril. 2020;114:388-397.
PubMed
25. Pacheco F, Oktay K. Current success and efficiency of autologous ovarian transplantation:a meta-analysis. Reprod Sci. 2017;24:1111-1120.
PubMed
26. Marin L, Bedoschi G, Kawahara T, et al.:History, Evolution and Current State of Ovarian Tissue Auto-Transplantation with Cryopreserved Tissue:a Successful Translational Research Journey from 1999 to 2020. Reprod Sci. 2020;27:955-962.
 
27. Andersen ST, Pors SE, Poulsen LC, et al.:Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue:a systematic review. Fertil Steril. 2019;112:908-921.
 
28. Diaz-Garcia C, Domingo J, Garcia-Velasco JA, et al.:Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments:a prospective cohort study. Fertil Steril. 2018;109:478-485. e2.
 
P.23 掲載の参考文献
1. 国立がん研究センターがん情報サービス「がん登録・統計」 https://ganjoho.jp/reg_stat/statistics/dl/index.html
 
2. 日本乳癌学会:年次統計2016年版
 
3. 日本乳癌学会編:乳癌診療ガイドライン治療編2018年版. 金原出版, 2018.
 
4. Lee SJ, Schover LR, Partridge AH, et al.:American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol. 2006;24:2917-2931.
 
5. Loren AW, Mangu PB, Beck LN, et al.:Fertility preservation for patients with cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2013;31:2500-2510.
 
6. Diaz-Garcia C, Domingo J, Garcia-Velasco J, et al.:Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments:a prospective cohort study. Fertil Steril. 2018;109:478-485.
PubMed
7. 日本癌治療学会 編:小児, 思春期・若年がん患者の妊孕性温存に関する診療ガイドライン2017年版. 金原出版, 2017.
 
8. Wapnir IL, Dignam JJ, Fisher B, et al.:Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103:478-488.
 
9. Azim HA, Kroman N, Paesmans M, et al. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status:a multicenter retrospective study. J Clin Oncol. 2013;31:73-79.
PubMed
10. 日本がん・生殖医療学会 編:乳がん患者の妊娠・出産と生殖医療に関する診療の手引き2017年版. 金原出版, 2017.
 
11. 齊藤英和, 石原 理, 久具宏司, ほか:平成23年度倫理委員会 登録・調査症委員会報告(2010年分の体外受精・胚移植等の臨床実施成績および2012年7月における登録施設名)日産婦誌. 2012;64:2110-2140.
 
12. Yu KD, Huang S, Zhang JX, et al.:Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer:a systematic review and meta-analysis. BMC Cancer. 2013;13:240.
PubMed
13. Goldrat O, Kroman N, Peccatori FA, et al.:Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. Eur J Cancer. 2015;51:1490-1496.
PubMed
14. Venn A, Watson L, Bruinsma F, et al.:Risk of cancer after use of fertility drugs with invitro fertilization. Lancet. 1999;354:1586-1590.
PubMed
15. 八木康道, 前多 力, 吉光 裕, ほか:転移巣切除後に化学療法を行った乳癌巨大卵巣転移の1例. 癌と化学療法. 2014;41:633-635.
Medical*Online
16. Dolmans MM, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99:1514-1522.
PubMed
17. Ford D, Easton DF, Stratton M, et al.:Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Hem Genet Mar. 1998;62:676-689.
 
18. Fleury A, Pirrello O, Maugard C, et al.:Breast cancer and ovarian tissue, cryopreservation:Review of the literature. J Gynecol Obset Hum Reprod. 2018;47:351-357.
 
19. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients with Cancer;ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
20. ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, et al.:ESHRE guideline:female fertility preservation. Hum Reprod Open. 2020;2020:hoaa052.
 
21. Dueholm Hjorth IM, Kristensen SG, Dueholm M, et al.:Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue. Fertil Steril. 2020;114:379-387.
 
22. Ahmad MF, Sugishita Y, Suzuki-Takahashi Y, et al.:Oncofertility Treatment Among Breast Cancer Women:A Paradigm Shift of Practice After a Decade of Service. J Adolesc Young Adult Oncol. 2020;9:496-501.
 
P.32 掲載の参考文献
1. Siegel RL, Miller KD, Jemal A:Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
 
2. Resetkova N, Hayashi M, Kolp LA, et al.:Fertility preservation for prepubertal girls:Update and Current Challenges. Curr Obstet Gynecol Rep. 2013;2:218-225.
PubMed
3. Sauvat F, Binart N, Poirot C, et al.:Preserving fertility in prepubertal children. Horm Res. 2009;71(Suppl 1):82-86.
 
4. Gellert SE, Pors SE, Kristensen SG, et al.:Transplantation of frozen-thawed ovarian tissue:an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018;35:561-570.
PubMed
5. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
6. Gravholt CH, Andersen NH, Conway GS, et al.:Clinical practice guidelines for the care of girls and women with Turner syndrome:proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. European journal of endocrinology. 2017;177:G1-G70.
PubMed
7. Hovatta O:Pregnancies in women with Turner's syndrome. Ann Med. 1999;31:106-110.
PubMed
8. Bryman I, Sylven L, Berntorp K, et al.:Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril. 2011;95:2507-2510.
PubMed
9. Birkebaek N, Cruger D, Hansen J, et al.:Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet. 2002;61:35-39.
PubMed
10. Bernard V, Donadille B, Zenaty D, et al.:Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod. 2016;31:782-788.
PubMed
11. Abir R, Fisch B, Nahum R, et al.:Turner's syndrome and fertility:current status and possible putative prospects. Hum Reprod Update. 2001;7:603-610.
PubMed
12. Hreinsson JG, Otala M, Fridstrom M, et al.:Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab. 2002;87:3618-3623.
PubMed
13. Reynaud K, Cortvrindt R, Verlinde F, et al.:Number of ovarian follicles in human fetuses with the 45, X karyotype. Fertil Steril. 2004;81:1112-1119.
PubMed
14. Weiss L:Additional evidence of gradual loss of germ cells in the pathogenesis of streak ovaries in Turner's syndrome. J Med Genet. 1971;8:540-544.
PubMed
15. Borgstrom B, Hreinsson J, Rasmussen C, et al.:Fertility preservation in girls with turner syndrome:prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab. 2009;94:74-80.
PubMed
16. Hreinsson JG, Otala M, Fridstrom M, et al.:Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab. 2002;87:3618-3623.
PubMed
17. Sutton EJ, McInerney-Leo A, Bondy CA, et al.:Turner syndrome:four challenges across the lifespan. Am J Med Genet A. 2005;139:57-66.
 
18. Nilsson J, Jervaeus A, Lampic C, et al.:'Will I be able to have a baby?' Results from online focus group discussions with childhood cancer survivors in Sweden. Hum Reprod. 2014;29:2704-2711.
 
19. Birgit B, Julius H, Carsten R, et al.:Fertility preservation in girls with turner syndrome:prognostic signs of the presence of ovarian follicles. J Clin Endocrinol Metab. 2009;94:74-80.
 
20. Grynberg M, Bidet M, Benard J, et al.:Fertility preservation in Turner syndrome. Fertil Steril. 2016;105:13-19.
PubMed
21. Huang J, Tulandi T, Holzer H, et al.:Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome:case report. Hum Reprod. 2008;23:336-339.
 
22. Balen A, Harris S, Chambers E, et al.:Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome. BJOG. 2010;117:238-242.
 
23. von Wolff M, Dittrich R, Liebenthron J, et al.:Fertility-preservation counselling and treatment for medical reasons:data from a multinational network of over 5000 women. Reprod Biomed Online. 2015;31:605-612.
PubMed
24. Finlayson C, Fritsch MK, Johnson EK, et al.:Presence of germ cells in disorders of sex development:implications for fertility potential and preservation. J Urol. 2017;197(3 Part 2):937-943.
 
25. Jensen AK, Rechnitzer C, Macklon K, et al.:Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls:focus on pubertal development. Hum Reprod. 2017;32:154-164.
 
26. Mamsen LS, Charkiewicz K, Anderson RA, et al.:Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation. Fertil Steril. 2019;111:1217-1225. e3.
 
27. Jansen FW, Kapiteyn K, Trimbos-Kemper T, et al.:Complications of laparoscopy:a prospective multicentre observational study. Br J Obstet Gynaecol. 1997;104:595-600.
PubMed
28. Di Pietro ML, Virdis A, Gonzalez-Melado F, et al.:Cryopreservation of ovarian tissue in pediatrics:what is the child's best interest? J Matern Fetal Neonatal Med. 2012;25:2145-2148.
 
29. Schleedoorn MJ, Mulder BH, Braat DDM, et al.:International consensus:ovarian tissue cryopreservation in young Turner syndrome patients:outcomes of an ethical Delphi study including 55 experts from 16 different countries. Hum Reprod. 2020;35:1061-1072.
PubMed
30. Borini A, Coticchio G:Oocyte quantity and quality are crucial for a perspective of fertility preservation in women with Turner syndrome. Fertil Steril. 2019;111:461-462.
PubMed
31. Salama M, Anazodo A, Woodruff TK:Preserving fertility in female patients with hematological malignancies:a multidisciplinary oncofertility approach. Ann Oncol. 2019;30:1760-1775.
PubMed
32. Lambertini M, Del Mastro L, Pescio MC, et al.:Cancer and fertility preservation:international recommendations from an expert meeting. BMC Med. 2016;14:1.
PubMed
33. Demeestere I, Simon P, Dedeken L, et al.:Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod. 2015;30:2107-2109.
PubMed
34. Salama M, Isachenko V, Isachenko E, et al.:Updates in preserving reproductive potential of prepubertal girls with cancer:Systematic review. Crit Rev Oncol Hematol. 2016;103:10-21.
PubMed
35. Practice Committee of American Society for Reproductive Medicine:Ovarian tissue cryopreservation:a committee opinion. Fertil Steril. 2014;101:1237-1243.
PubMed
36. Grynberg M, Poulain M, Sebag-Peyrelevade S, et al.:Ovarian tissue and follicle transplantation as an option for fertility preservation. Fertil Steril. 2012;97:1260-1268.
PubMed
37. Imbert R, Moffa F, Tsepelidis S, et al.:Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility:a 12-year retrospective analysis. Hum Reprod. 2014;29:1931-1940.
PubMed
38. Salama M, Woodruff TK:New advances in ovarian autotransplantation to restore fertility in cancer patients. Cancer Metastasis Rev. 2015;34:807-822.
PubMed
39. Dolmans MM, Donnez J, Cacciottola L:Fertility Preservation:The Challenge of Freezing and Transplanting Ovarian Tissue. Trends Mol Med. 2020;S1471-4914(20)30286-0.
 
40. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
41. Rosendahl M, Greve T, Andersen CY:The safety of transplanting cryopreserved ovarian tissue in cancer patients:a review of the literature. J Assist Reprod Genet. 2013;30:11-24.
PubMed
42. Bastings L, Beerendonk CC, Westphal JR, et al.:Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy:a systematic review. Hum Reprod Update. 2013;19:483-506.
 
43. Dolmans MM, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99:1514-1522.
PubMed
44. Shapira M, Raanani H, Barshack I, et al.:First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109:48-53.
 
45. Meirow D, Hardan I, Dor J, et al.:Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23:1007-1013.
PubMed
46. Greve T, Clasen-Linde E, Andersen MT, et al.:Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120:4311-4316.
PubMed
47. Dolmans MM, Jadoul P, Gilliaux S, et al.:A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013;30:305-314.
PubMed
48. Soares M, Saussoy P, Maskens M, et al.:Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients. Br J Haematol. 2017;178:231-239.
PubMed
49. Oktay K, Harvey BE, Partridge AH, et al.:Fertility preservation in patients with cancer:ASCO clinical practice guideline update. J Clin Oncol. 2018;36:1994-2001.
PubMed
50. Siegel RL, Miller KD, Jemal A:Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.
PubMed
51. Steliarova-Foucher E, Colombet M, Ries LA, et al.:International incidence of childhood cancer, 2001-10:a population-based registry study. Lancet Oncol. 2017;18:719-731.
PubMed
52. Nguyen TYT, Cacciottola L, Camboni A, et al.:Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours. Hum Reprod. 2021;deaa353.
PubMed
53. McDowell HP:Update on childhood rhabdomyosarcoma. Arch Dis Child. 2003;88:354-357.
PubMed
54. Gurney JG, Severson RK, Davis S, et al.:Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995;75:2186-2195.
PubMed
55. Ognjanovic S, Linabery AM, Charbonneau B, et al.:Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009;115:4218-4226.
PubMed
56. Smith MA, Altekruse SF, Adamson PC, et al.:Declining childhood and adolescent cancer mortality. Cancer. 2014;120:2497-2506.
PubMed
57. Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol. 2010;28:4831-4841.
 
58. Balamuth NJ, Womer RB:Ewing's sarcoma. Lancet Oncol. 2010;11:184-192.
PubMed
59. Raciborska A, Bilska K, Filipp E, et al.:Ovarian function in female survivors after multimodal Ewing sarcoma therapy. Pediatr Blood Cancer. 2015;62:341-345.
PubMed
60. Sullivan HC, Shulman SC, Olson T, et al.:Unusual presentation of metastatic Ewing sarcoma to the ovary in a 13 year-old:a case report and review. Fetal Pediatr Pathol. 2012;31:159-163.
 
61. Dolmans MM, Iwahara Y, Donnez J, et al.:Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients. Hum Reprod. 2016;31:2292-2302.
PubMed
62. Abir R, Feinmesser M, Yaniv I, et al.:Occasional involvement of the ovary in Ewing sarcoma. Hum Reprod. 2010;25:1708-1712.
PubMed
63. Schifflers S, Delbecque K, Galant C, et al.:Microscopic Infiltration of Cryopreserved Ovarian Tissue in 2 Patients With Ewing Sarcoma. J Pediatr Hematol Oncol. 2018;40:e167-e170.
PubMed
P.44 掲載の参考文献
1. Seki S, Mazur P:Stability of mouse oocytes at -80℃:the role of the recrystallization of intracellular ice. Reproduction. 2011;141:407-415.
 
2. Seki S, Mazur P:The dominance of warming rate over cooling rate in the survival of mouse oocytes subjected to a vitrification procedure. Cryobiology. 2009;59:75-82.
PubMed
3. Seki S, Mazur P:Ultra-rapid warming yields high survival of mouse oocytes cooled to -196℃ in dilutions of a standard vitrification solution. PLoS One. 2012;7:e36058.
 
4. Kasai M, Ito K, Edashige K:Morphological appearance of the cryopreserved mouse blastocyst as a tool to identify the type of cryoinjury. Hum Reprod. 2002;17:1863-1874.
PubMed
5. Bou G, Liu L, Zheng Z, et al.:Effect of chilling on porcine germinal vesicle stage oocytes at the subcellular level. Cryobiology. 2009;59:54-58.
 
6. Martino A, Songsasen N, Leibo SP:Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling. Biol Reprod. 1996;54:1059-1069.
PubMed
7. Kuwayama M, Vajta G, Kato O, et al.:Highly efficient vitrification method for cryopreservation of human oocyte. Reprod Biomed Online. 2005;11:300-308.
PubMed
8. Whittingham DG, Leibo SP, Mazur P:Survival of mouse embryos frozen to -196℃ and -269℃ . Science. 1972;178. 411-414.
 
9. Mazur P:Equilibrium, quasi-equilibrium, and nonequilibrium freezing of mammalian embryos. Cell Biophys. 1990;17:53-92.
PubMed
10. Kasai M, Zhu SE, Pedro PB, et al.:Fracture damage of embryos and its prevention during vitrification and warming. Cryobiology. 1996;33:459-464.
PubMed
11. Pedro PB, Zhu SE, Makino N, et al.:Effects of hypotonic stress on the survival of mouse oocytes and embryos at various stages. Cryobiology. 1997;35:150-158.
PubMed
12. Edashige K, Asano A, An TZ, et al.:Restoration of resistance to osmotic swelling of vitrified mouse embryos by short-term culture. Cryobiology. 1999;38:273-280.
PubMed
13. Pedro PB, Sakurai T, Keisuke E:Effects of osmotic shrinkage on the survival of mouse oocytes and embryos at various developmental stages. J Mammal Ova Res. 1997;14:66-71.
 
14. Edashige K, Yamaji Y, Kleinhans FW, et al.:Artificial expression of aquaporin-3 improves the survival of mouse oocytes after cryopreservation. Biol Reprod. 2003;68:87-94.
PubMed
15. Edashige K, Tanaka M, Ichimaru N, et al.:Channel-dependent permeation of water and glycerol in mouse morulae. Biol Reprod. 2006;74:625-632.
PubMed
16. Edashige K, Ohta S, Tanaka M, et al.:The role of aquaporin 3 in the movement of water and cryoprotectants in mouse morulae. Biol Reprod. 2007;77:365-375.
PubMed
17. Pedro PB, Yokoyama E, Zhu SE, et al.:Permeability of mouse oocytes and embryos at various developmental stages to five cryoprotectants. J Reprod Dev. 2005;51:235-246.
PubMed
18. Jin B, Kawai Y, Hara T, et al.:Pathway for the movement of water and cryoprotectants in bovine oocytes and embryos. Biol Reprod. 2011;85:834-847.
PubMed
19. Ford P, Merot J, Jawerbaum A, et al.:Water permeability in rat oocytes at different maturity stages:aquaporin-9 expression. J Membr Biol. 2000;176:151-158.
PubMed
20. Skowronski MT, Kwon TH, Nielsen S:Immunolocalization of aquaporin 1, 5, and 9 in the female pig reproductive system. J Histochem Cytochem. 2009;57:61-67.
PubMed
21. Sales AD, Brito IR, de Lima LF, et al.:Expression and localization of aquaporin 3(AQP3)in folliculogenesis of ewes. Acta Histochem. 2014;116. 831-837.
PubMed
22. Thoroddsen A, Dahm-Kahler P, Lind AK, et al.:The water permeability channels aquaporins 1-4 are differentially expressed in granulosa and theca cells of the preovulatory follicle during precise stages of human ovulation. J Clin Endocrinol Metab. 2011;96:1021-1028.
PubMed
23. Acker JP, Elliott JA, McGann LE:Intercellular ice propagation:experimental evidence for ice growth through membrane pores. Biophys J. 2001;81:1389-1397.
PubMed
24. Rall WF, Fahy GM:Ice-free cryopreservation of mouse embryos at -196℃ by vitrification. Nature. 1985;313:573-575.
 
P.49 掲載の参考文献
1. 日本産科婦人科学会:医学的適応による未受精卵子, 胚(受精卵)および卵巣組織の凍結・保存に関する見解 2019年改訂. http://www.jsog.or.jp/modules/statement/index.php?content_id=23
 
2. 日本生殖医学会:医学的適応による未受精卵子あるいは卵巣組織の凍結・保存のガイドライン 2013年. http://www.jsrm.or.jp/guideline-statem/guideline_2013_01.html
 
3. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology:Mature oocyte cryopreservation:a guideline. Fertil Steril. 2013;99:37-43.
 
4. National Institute for Health and Care Excellence:Fertility-Assessment and treatment for people with fertility problems. 2013. https://www.nice.org.uk/guidance/cg156
 
5. von Wolff M, Montag M, Dittrich R, et al.:Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network Ferti-PROTEKT. Arch Gynecol Obstet. 2011;284:427-435.
 
6. Cobo A, Diaz C:Clinical application of oocyte vitrification:a systematic review and meta-analysis of randomized controlled trials. Fertil Steri. 2011;96:277-285.
 
7. Cil AP, Bang H, Oktay K:Age-specific probability of live birth with oocyte cryopreservation:an individual patient data meta-analysis. Fertil Steril. 2013;100:492-499. e3.
 
8. Glujovsky D, Riestra B, Sueldo C, et al.:Vitrification versus slow freezing for women undergoing oocyte cryopreservation. Cochrane Database Syst Rev. 2014;(9):CD010047.
PubMed
9. Centers for Disease Control and Prevention:2017 Assisted Reproductive Technology Fertility Clinic Success Rates Report. 2018. https://www.cdc.gov/art/reports/2017/fertility-clinic. html(Accessed on January 13, 2020)
 
10. Cobo A, Garcia-Velasco JA, Coello A, et al.:Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755-764. e8.
 
11. Cobo A, Garcia-Velasco JA, Domingo J, et al.:Elective and Onco-fertility preservation:factors related to IVF outcomes. Hum Reprod. 2018;33:2222-2231.
 
12. Goldman KN, Kramer Y, Hodes-Wertz B, et al.:Long-term cryopreservation of human oocytes does not increase embryonic aneuploidy. Fertil Steril. 2015;103:662-668.
 
13. Chamayou S, Sicali M, Alecci C, et al.:The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing. J Assist Reprod Genet. 2017;34:479-486.
PubMed
14. Noyes N, Porcu E, Borini A:Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769-776.
PubMed
15. Winslow KL, Yang D, Blohm PL, et al.:Oocyte cryopreservation:a three year followup of sixteen births. Fertil Steril. 2001;76:S120-S121.
 
16. Porcu E, Fabbri R, Damiano G, et al.:Clinical experience and applications of oocyte cryopreservation. Mol Cell Endocrinol. 2000;169:33-37.
 
17. Chian RC, Huang JY, Tan SL, et al.:Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod Biomed Online. 2008;16:608-610.
PubMed
18. 日本産科婦人科学会:精子の凍結保存に関する見解 2018年改訂. http://www.jsog.or.jp/modules/statement/index.php?content_id=26
 
19. Ethics Committee of the American Society for Reproductive Medicine:Fertility preservation and reproduction in patients facing gonadotoxic therapies:an Ethics Committee opinion. Fertil Steril. 2018;110:380-386.
PubMed
20. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
21. Ferrari S, Paffoni A, Filippi F, et al.:Sperm cryopreservation and reproductive outcome in male cancer patients:a systematic review. Reprod Biomed Online. 2016;33:29-38.
PubMed
22. 日本産科婦人科学会:令和元年度倫理委員会 登録・調査小委員会報告(2018年分の体外受精・胚移植等の臨床実施成績および2020年7月における登録施設名). 日本産科婦人科学会雑誌. 2020;72:1229-1249.
 
23. Oktay K, Turan V, Bedoschi G, et al.:Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. J Clin Oncol. 2015;33:2424-2429.
PubMed
24. Marklund A, Lundberg FE, Eloranta S, et al.:Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation. JAMA Oncol. 2021;7:86-91.
PubMed
25. 日本がん・生殖医療学会:オンラインレジストリ. http://www.j-sfp.org/about/registry.html
 
P.56 掲載の参考文献
1. Practice Committee of the American Society for Reproductive Medicine:Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy:a committee opinion. Fertil Steril. 2019;112:1022-1033.
 
2. The ESHRE Guideline Group on Female Fertility Preservation:ESHRE Guideline:female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
 
3. Dittrich R, Lotz L, Keck G, et al.:Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97:387-390.
PubMed
4. Silber SJ:Ovary cryopreservation and transplantation for fertility preservation. Mol Hum Reprod. 2012;18:59-67.
PubMed
5. Hovatta O, Silye R, Krausz T, et al.:Cryopreservation of human ovarian tissue using dimeth-ylsulphoxide and propanediol-sucrose as cryoprotectants. Hum Reprod. 1996;11:1268-1272.
 
6. Gosden RG, Baild DT, Wade JC, et al.:Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod. 1994;9:597-603.
 
7. Leonel ECR, Lucci CM, Amorim CA:Cryopreservation of human ovarian tissue:a review. Transfus Med Hemother. 2019;46:173-181.
 
8. Pacheco F, Oktay K:Current success and efficiency of autologous ovarian transplantation:a meta-analysis. Reprod Sci. 2017;24:1111-1120.
PubMed
9. Shapira M, Raanani H, Barshack I, et al.:First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Feril Steril. 2018;109:48-53.
 
10. Donnez J, Jadoul P, Pirard C, et al.:Live birth after transplantation of frozen-thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil Steril. 2012;98:720-725.
PubMed
11. Milenkovic M, Wallin A, Ghahremani M, et al.:Whole sheep ovary cryopreservation:evaluation of a slow freezing protocol with dimethylsulphoxide. J Assist Reprod Genet. 2011;28:7-14.
PubMed
12. Milenkovic M, Diaz-Garcia C, Wallin A, et al.:Viability and function of the cryopreserved whole rat ovary:comparison between slow-freezing and vitrification. Fertil Steril. 2012;97:1176-1182.
PubMed
P.64 掲載の参考文献
1. Hovatta O, Silye R, Krausz T, et al.:Cryopreservation of human ovarian tissue using dimethylsulphoxide and propanediol-sucrose as cryoprotectants. Hum Reprod. 1996;11:1268-1272.
PubMed
2. Newton H, Aubard Y, Rutherford A, et al.:Low temperature storage and grafting of human ovarian tissue. Hum Reprod. 1996;11:1487-1491.
PubMed
3. Hovatta O.:Methods for cryopreservation of human ovarian tissue. RBOnline. 2005;10:729-734.
PubMed
4. von Wolff M, Donnez J, Hovatta O, et al.:Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy? A technique in its infancy but already successful in fertility preservation. Eur J Cancer. 2009;45:1547-1553.
PubMed
5. Hashimoto S, Suzuki N, Ishizuka B, et al.:Cryopreservation of female germ cells and ovarian tissues for fertility preservation. Reprod Med Biol. 2011;10:161-169.
PubMed
6. Deanesly R.:Immature rat ovaries grafted after freezing and thawing. J Endocrinol. 1954;11:197-200.
PubMed
7. Green SH, Smith AU, Zuckerman S:The number of oocytes in ovarian autografts after freezing and thawing. J Endocrinol. 1956;13:330-334.
PubMed
8. Parkes AS:Factors affecting the viability of frozen ovarian tissue. J Endocrinol. 1958;17:337-343.
 
9. Parrott DM:The fertility of mice with orthotopic ovarian grafts derived from frozen tissue. J Reprod Fertil. 1960;1:230-241.
 
10. Donnez J, Dolmans MM, Demylle D, et al.:Live birth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
 
11. Meirow D, Levron J, Eldar-Geva T, et al.:Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318-321.
 
12. Dolmans MM, Donez J, Camboni A, et al.:IVF outcomes in patients with orthotopically transplanted ovarian tissue. Hum Reprod. 2009;24:2778-2787.
 
13. Sugimoto M, Maeda S, Manabe N, et al.:Development of infantile rat ovaries autotransplanted after cryopreservation by vitrification. Theriogenology. 2000;53:1093-1103.
PubMed
14. Tokieda Y, Ishiwata I, Segino M, et al.:Establishment of a novel method for cryopreservation and thawing of the mouse ovary. Hum Cell. 2002;15:230-237.
PubMed
15. Migishima F, Suzuki-Migishima R, Song SY, et al.:Successful cryopreservation of mouse ovaries by vitrification. Biol Reprod. 2003;68:881-887.
PubMed
16. Chen SU, Chien CL, Wu MY, et al.:Novel direct cover vitrification for cryopreservation of ovarian tissues increases follicle viability and pregnancy capability in mice. Hum Reprod. 2006;21:2794-2800.
PubMed
17. Wang Y, Xiao Z, Li L, et al.:Novel needle immersed vitrification:a practical and convenient method with potential advantages in mouse and human ovarian tissue cryopreservation. Hum Reprod. 2008;23:2256-2265.
 
18. Keros V, Xella S, Hultenby K, et al.:Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod. 2009;24:1670-1683.
PubMed
19. Kagawa N, Silber S, Kuwayama M:Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online. 2009;18:568-577.
PubMed
20. Hashimoto S, Suzuki N, Yamanaka M, et al.:Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues vitrified ultra-rapidly by direct plunging into liquid nitrogen. Reprod Biomed Online. 2010;21:501-509.
 
21. Kawamura K, Cheng Y, Suzuki N, et al.:Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110:17474-17479.
PubMed
22. Sugishita Y, Okamoto N, Uekawa A, et al.:Oocyte retrieval after heterotopic transplantation of ovarian tissue cryopreserved by closed vitrification protocol. J Assist Reprod Genet. 2018;35:2037-2048.
PubMed
23. Hashimoto S, Suzuki N, Tsuji Y, et al.:Ultra-rapid vitrification supported follicle morphologies of cynomolgus monkeys after freezing compared to conventional vitrification and slow freezing. World Congress on Fertilization Preservation. OC 23, 2009.
 
24. Steponkus PL, Myers SP, Lynch DV, et al.:Cryopreservation of Drosophila melanogaster embryos. Nature. 1990;345:170-172.
PubMed
25. Mazur P, Cole KW, Hall WH, et al.:Cryohistological preservation of Drosophila embryos. Science. 1992;258, 1932-1935.
 
26. Rall WF, Fahy GM:Ice-free cryopreservation of mouse embryos at-196 degrees C by vitrification. Nature. 1985;313:573-575.
PubMed
27. Yokota Y, Sato S, Yokota M, et al.:Successful pregnancy following blastocyst vitrification. Hum Reprod. 2000;15:1802-1803.
PubMed
28. 葛西孫三郎:生殖系列細胞の保存. 生命の誕生に向けて. 日本哺乳動物卵子学会, 2005, pp. 35-43.
 
29. Kasai M:Vitrification:Refined strategy for the cryopreservation of mammalian embryos. J Mamm Ova Res. 1997;14:17-28.
 
30. Martino A, Songsasen N, Leibo SP:Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling. Biol Reprod. 1996;54:1059-1069.
PubMed
31. Vajta G, Holm P, Kuwayama M, et al.:Open pulled straw(OPS)vitrification:a new way to reduce cryoinjuries of bovine ova and embryos. Mol Reprod Dev. 1998;51:53-58.
PubMed
32. Dinnyes A, Dai Y, Jiang S, et al.:High developmental rates of vitrified bovine oocytes following parthenogenetic activation, in vitro fertilization, and somatic cell nuclear transfer. Biol Reprod. 2000;63:513-518.
PubMed
33. Papis K, Shimizu M, Izaike Y:Factors affecting the survivability of bovine oocytes vitrified in droplets. Theriogenology. 2000;54:651-658.
PubMed
34. Hochi S, Hirabayashi M, Hirao M, et al.:Effects of cryopreservation of pronuclearstage rabbit zygotes on the morphological survival, blastocyst formation, and full-term development after DNA microinjection. Mol Reprod Dev. 2001;60:227-232.
PubMed
35. Matsumoto H, Jiang JY, Tanaka T, et al.:Vitrification of large quantities of immature bovine oocytes using nylon mesh. Cryobiology. 2001;42:139-144.
PubMed
36. Ishimori H, Takahashi Y, Kanagawa H:Factors affecting survival of mouse blastocysts vitrified by a mixture of ethylene glycol and dimethyl sulfoxide. Theriogenology. 1992;38:1175-1185.
PubMed
37. Gandolfi F, Paffoni A, Brambilla EP, et al.:Efficiency of equilibrium cooling and vitrification procedures for the cryopreservation of ovarian tissue:comparative analysis between human and animal models. Fertil Steril. 2006;85:1150-1156.
 
38. Suzuki N, Hashimoto S, Igarashi S, et al.:Assessment of long term function of heterotopic transplants of vitrified ovarian tissue in cynomolgus monkeys. Hum Reprod. 2012;27:2420-2429.
PubMed
39. Igarashi S, Suzuki N, Hashimoto S, et al.:Heterotopic autotransplantation of ovarian cortex in cynomolgus monkeys. Hum Cell. 2010;23:26-34.
PubMed
40. Donnez J, Silber S, Andersen C, et al.:Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43:437-450.
 
41. Nottola SA, Camboni A, Van Langendonckt A, et al.:Cryopreservation and xenotransplantation of human ovarian tissue:an ultrastructural study. Fertil Steril. 2008;90:23-32.
PubMed
42. Meirow D, Levron J, Eldar-Geva T, et al.:Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue:endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril. 2007;87:418. e7-418. e15.
 
43. Andersen CY, Rosendahl M, Byskov AG, et al.:Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23:2266-2272.
PubMed
44. Donnez J, Dolmans MM, Demylle D, et al.:Restoration of ovarian function after orthotopic(intraovarian and periovarian)transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia:case report. Hum Reprod. 2006;21:183-188.
 
45. Oktay K, Buyuk E, Veeck L, et al.:Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;363:837-840.
PubMed
46. Kim SS, Lee WS, Chung MK, et al.:Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue:8-year experience in cancer patients. Fertil Steril. 2009;91:2349-2354.
PubMed
47. Yang HY, Cox SL, Jenkin G, et al.:Graft site and gonadotrophin stimulation influences the number and quality of oocytes from murine ovarian tissue grafts. Reproduction. 2006;131:851-859.
PubMed
48. Stevenson TL, Lashen H:Empty follicle syndrome:the reality of a controversial syndrome, a systematic review. Fertil Steril. 2008;90:691-698.
PubMed
49. Bielanski A:The potential for animal and human germplasm contamination through assisted reproductive technologies. Trends Reprod Biol. 2006;2:13-36.
 
50. Bielanski A, Vajta G:Risk of contamination of germplasm during cryopreservation and cryobanking in IVF units. Hum Reprod. 2009;24:2457-2467.
PubMed
51. Larman M, Gardner D:Vitrification of mouse embryos with super-cooled air. Fertil Steril. 2011;95:1462-1466.
PubMed
52. Hashimoto S, Amo A, Hama S, et al.:A closed system supports the developmental competence of human embryos after vitrification. J Assist Reprod Genet. 2013;30:371-376.
PubMed
53. Larman M, Hashimoto S, Morimoto Y, et al.:Cryopreservation in ART and concerns with contamination during cryobanking. Reprod Med Biol., 2014;13:107-117.
PubMed
54. Hashimoto S, Suzuki N, Amo A, et al.:Good thermally conducting material supports follicle morphologies of porcine ovaries cryopreserved with ultrarapid vitrification. J Reprod Dev. 2013;59:496-499.
PubMed
55. Sheikhi M, Hultenby K, Niklasson B, et al.:Preservation of human ovarian follicles within tissue frozen by vitrification in a xeno-free closed system using only ethylene glycol as a permeating cryoprotectant. Fertil Steril 2013;100:170-177.
 
56. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
57. Greve T, Clasen-Linde E, Andersen MT, et al.:Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120:4311-4316.
PubMed
58. Jadoul P, Guilmain A, Squifflet J, et al.:Efficacy of ovarian tissue cryopreservation for fertility preservation:lessons learned from 545 cases.;Hum Reprod 2017;32:1046-1054.
PubMed
59. Hoekman EJ, Louwe LA, Rooijers M, et al.:Ovarian tissue cryopreservation:Low usage rates and high live-birth rate after transplantation. Acta Obstet Gynecol Scand. 2020;99:213-221.
PubMed
P.86 掲載の参考文献
1. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
2. Dolmans MM, von Wolff M, Poirot C, et al.:Transplantation of cryopreserved ovarian tissue in a series of 285 women:a review of five leading European centers. Fertil Steril. 2021;115:1102-1115.
 
3. Dolmans MM, Falcone T, Patrizio P:Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. Fertil Steril. 2020;114:279-280.
PubMed
4. Shapira M, Dolmans MM, Silber S, et al.:Evaluation of ovarian tissue transplantation:results from three clinical centers. Fertil Steril. 2020;114:388-397.
PubMed
5. Kuwayama M, Vajta G, Kato O, et al.:Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005;11:300-308.
PubMed
6. Hashimoto S, Suzuki N, Yamanaka M, et al.:Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues. Reprod Biomed Online. 2010;21:501-509.
PubMed
7. Suzuki N, Hashimoto S, Igarashi S, et al.:Assessment of long-term function of heterotopic transplants of vitrified ovarian tissue in cynomolgus monkeys. Hum Reprod. 2012;27:2420-2429.
PubMed
8. Suzuki N, Yoshioka N, Takae S et al.:Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30:608-615.
PubMed
9. Keros V, Xella S, Hultenby K, et al.:Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod. 2009;24:1670-1683.
PubMed
10. Sheikhi M, Hultenby K, Niklasson B, et al.:Clinical grade vitrification of human ovarian tissue:an ultrastructural analysis of follicles and stroma in vitrified tissue. Hum Reprod. 2011;26:594-603.
PubMed
11. Ting AY, Yeoman RR, Lawson MS, et al.:Synthetic polymers improve vitrification outcomes of macaque ovarian tissue as assessed by histological integrity and the in vitro development of secondary follicles. Cryobiology. 2012;65:1-11.
PubMed
12. Ting AY, Yeoman RR, Lawson MS, et al.:In vitro development of secondary follicles from cryopreserved rhesus macaque ovarian tissue after slow-rate freeze or vitrification. Hum Reprod. 2011;26:2461-2472.
PubMed
13. Kagawa N, Silber S, Kuwayama M:Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online. 2009;18:568-577.
PubMed
14. Yong KW, Laouar L, Elliott JAW, et al.:Review of non-permeating cryoprotectants as supplements for vitrification of mammalian tissues. Cryobiology. 2020;96:1-11.
PubMed
15. Shahsavari MH, Alves KA, Alves BG, et al.:Impacts of different synthetic polymers on vitrification of ovarian tissue. Cryobiology. 2020;94:66-72.
PubMed
16. Joaquim DC, Borges ED, Viana IGR, et al.:Risk of Contamination of Gametes and Embryos during Cryopreservation and Measures to Prevent Cross-Contamination. Biomed Res Int. 2017;2017:1840417.
PubMed
17. Bielanski A:Biosafety in embryos and semen cryopreservation, storage, management and transport. Adv Exp Med Biol. 2014;753:429-465.
PubMed
18. De los Santos MJ, Apter S, Coticchio G, et al.:Revised guidelines for good practice in IVF laboratories(2015). Hum Reprod. 2016;31:685-686.
PubMed
19. Sugishita Y, Okamoto N, Uekawa A, et al.:Oocyte retrieval after heterotopic transplantation of ovarian tissue cryopreserved by closed vitrification protocol. J Assist Reprod Genet. 2018;35:2037-2048.
PubMed
20. Sato T, Sugishita Y, Suzuki Y, et al.:Radiofrequency identification tag system improves the efficiency of closed vitrification for cryopreservation and thawing of bovine ovarian tissues. J Assist Reprod Genet. 2019;36:2251-2257.
PubMed
P.98 掲載の参考文献
1. Angell CA:Supercooled water. In Water:A Comprehensive Treatise. Vol.7, Water and Aqueous Solutions at Subzero Temperatures. (ed. Franks F), chap.1, Plenum Press, NewYork, 1982.
 
2. Donnez J, Silber S, Andersen CY, et al.:Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med. 2011;43:437-450.
 
3. Wagner M, Yoshihara M, Douagi I, et al.:Single-cell analysis of human ovarian cortex identifies distinct cell populations but no oogonial stem cells. Nat Commun. 2020;11:1147.
PubMed
4. Kagawa N, Silber S, Kuwayama M.:Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online. 2009;18:568-577.
PubMed
5. 理科年表 平成25年(第86冊). 物55(415), 丸善出版.
 
6. Schuring AN, Fehm T, Behringer K, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I:Indications for fertility preservation. Arch Gynecol Obstet. 2018;297:241-255.
PubMed
7. von Wolff M, Germeyer A, Liebenthron J, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II:fertility preservation techniques. Arch Gynecol Obstet. 2018;297:257-267.
PubMed
8. Dolmans MM, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;997:1514-1522.
 
9. Peek R, Bastings L, Westphal JR, et al.:A preliminary study on a new model system to evaluate tumour-detection and tumour-purging protocols in ovarian cortex tissue intended for fertility preservation. Hum Reprod. 2015;30:870-876.
 
10. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
11. The FertiPROTEKT Resister(https://fertiprotekt.com/fertiprotekt-the-register)
 
12. Shi Q, Xie Y, Wang Y, et al.:Vitrification versus slow freezing for human ovarian tissue cryopreservation:a systematic review and meta-analysis. Sci Rep. 2017;7:8538.
PubMed
13. Leonel E, Lucci C, Amorim C. et al.:Cryopreservation of Human Ovarian Tissue:A Review. Transfus Med Hemother. 2019;46:173-181.
 
P.103 掲載の参考文献
1. Donnez J, Bassil S:Indications for cryopreservation of ovarian tissue. Hum Reprod Update. 1998;4:248-259.
PubMed
2. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
3. Donnez J, Dolmans MM:Fertility preservation in women. N Engl J Med. 2017;377:1657-1665.
PubMed
4. 日本癌治療学会編:小児, 思春期・若年がん患者の妊孕性温存に関する診療ガイドライン2017年版. 金原出版, 2017.
 
5. Arav A, Natan Y:Directional freezing:a solution to the methodological challenges to preserve large organs. Semin Reprod Med. 2009;27:438-442.
 
6. Maffei S, Pennarossa G, Brevini TA, et al.:Beneficial effect of directional freezing on in vitro viability of cryopreserved sheep whole ovaries and ovarian cortical slices. Hum Reprod. 2014;29:114-124.
PubMed
7. Arav A, Patrizio P:Techniques of cryopreservation for ovarian tissue and whole ovary. Clin Med Insights Reprod Health. 2019;13:1-5.
 
8. Fuller BJ:Cryoprotectants:the essential antifreezes to protect life in the frozen state. Cryo Letters. 2004;25:375-388.
PubMed
9. Wowk B:Anomalous high activity of a subfraction of polyvinyl alcohol ice blocker. Cryobiology. 2005;50:325-331.
PubMed
10. Congdon T, Notman R, Gibson MI:Antifreeze(glycol)protein mimetic behavior of poly(vinyl alcohol):detailed structure ice recrystallization inhibition activity study. Biomacromolecules. 2013;14:1578-1586.
 
11. Hashimoto S, Suzuki N, Yamanaka M, et al.:Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues. Reprod Biomed Online. 2010;21:501-509.
PubMed
12. Ting AY, Yeoman RR, Lawson MS, et al.:Synthetic polymers improve vitrification outcomes of macaque ovarian tissue as assessed by histological integrity and the in vitro development of secondary follicles. Cryobiology. 2012;65:1-11.
PubMed
13. Fujihara M, Kaneko T, Inoue-Murayama M:Vitrification of canine ovarian tissues with polyvinylpyrrolidone preserves the survival and developmental capacity of primordial follicles. Sci Rep. 2019;9:3970.
 
14. Montano Vizcarra DA, Pinto Silva Y, Bezerra Bruno J, et al.:Use of synthetic polymers improves the quality of vitrified caprine preantral follicles in the ovarian tissue. Acta Histochem. 2020;122:151484.
PubMed
15. Shahsavari MH, Alves KA, Alves BG, et al.:Impacts of different synthetic polymers on vitrification of ovarian tissue. Cryobiology. 2020;94:66-72.
PubMed
16. Talevi R, Barbato V, Fiorentino I, et al.:Successful slush nitrogen vitrification of human ovarian tissue. Fertil Steril. 2016;105:1523-1531. e1.
 
17. Barbato V, Gualtieri R, Capriglione T, et al.:Slush nitrogen vitrification of human ovarian tissue does not alter gene expression and improves follicle health and progression in long-term in vitro culture. Fertil Steril. 2018;110:1356-1366.
 
18. Wakayama T, Yanagimachi R:Development of normal mice from oocytes injected with freeze-dried spermatozoa. Nat Biotechnol. 1998;16:639-641.
PubMed
19. Natan D, Nagler A, Arav A:Freeze-drying of mononuclear cells derived from umbilical cord blood followed by colony formation. PLoS One. 2009;4:e5240.
PubMed
P.112 掲載の参考文献
1. Donnez J, Bassil S:Indications for cryopreservation of ovarian tissue. Hum Reprod Update. 1998;4:248-259.
PubMed
2. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
3. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
4. Pacheco F, Oktay K:Current success and efficiency of autologous ovarian transplantation:A Meta-Analysis. Reprod Sci. 2017;24:1111-1120.
PubMed
5. Leonel ECR, Lucci CM, Amorim CA:Cryopreservation of human ovarian tissue:A review. Transfus Med Hemother. 2019;46:173-181.
 
6. Peter M:Freezing of living cells:mechanisms and implications. Am J Physiol. 1984;247:C125-C142.
 
7. Gosden RG, Baird DT, Wade JC, et al.:Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196℃. Hum Reprod. 1994;9:597-603.
 
8. Bautista JAN, Kanagawa H:Current status of vitrification of embryo and oocytes in domestic animals:Ethylene glycol as an emerging cryoprotectant of choice. Jpn J Vet Res. 1998;45:183-191.
 
9. Amorim CA, David A, Langendonkt AV, et al.:Vitrification of human ovarian tissue:effect of different solution and procedures. Fertil Stelil. 2011;95:1094-1097.
 
10. Cobo A, Diaz C:Clinical application of oocyte vitrification:a systematic review and meta-analysis of randomized controlled trials. Fertil Stelil. 2011;96:277-285.
PubMed
11. Cil AP, Bang H, Oktay K:Age-specific probability of live birth with oocyte cryopreservation:an individual patient data meta-analysis. Fertil Stelil. 2013;100:492-499. e3.
 
12. Rienzi L, Gracia C, Maggiulli R, et al.:Oocyte, embryo and blastocyst cryopreservation in ART:systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017;23:139-155.
PubMed
13. Kawamura K, Cheng Y, Suzuki N, et al.:Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110:17474-17179.
PubMed
14. Suzuki N, Yoshioka N, Takae S, et al.:Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30:608-615.
PubMed
15. Kiseleva M, Malinova I, Komarova E, et al.:The Russian experience of autotransplantation of vitrified ovarian tissue to a cancer patient. Gynecol Endocrinol. 2014;30(suppl 1):30-31.
 
16. Keros V, Xella S, Hultenby K, et al.:Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod. 2009;24:1670-1683.
PubMed
17. Fabbri R, Vicenti R, Macciocca M, et al.:Good preservation of stromal cells and no apoptosis in human ovarian tissue after Vitrification. Biomed Res Int. 2014;2014:673537.
PubMed
18. Silber S, Kagawa N, Kuwayama M, et al.:Duration of fertility after fresh and frozen ovary transplantation. Fertil Stelil. 2010;94:2191-2196.
PubMed
19. Oktem O, Alper E, Balaban B, et al.:Vitrified human ovaries have fewer primordial follicles and produce less antimullerian hormone than slow-frozen ovaries. Fertil Steril. 2011;95:2661-2664. e1.
 
20. Rahimi G, Isachenko V, Todorov P, et al.:Apoptosis in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. Cryo Letters. 2009;30:300-309.
PubMed
21. Lee K, Ryu K, Kim B, et al.:Comparison between slow freezing and vitrification for human ovarian tissue cryopreservation and xenotransplantation. Int J Mol Sci. 2019;20:3346.
 
22. Li YB, Zhou CQ, Yang GF, et al.:Modified vitrification method for cryopreservation of human ovarian tissues. Chin Med J. 2007;120:110-114.
PubMed
23. Huang L, Mo Y, Wang W, et al.:Cryopreservation of human ovarian tissue by solidsurface vitrification. Eur J Obstet Gynecol Reprod Biol. 2008;139:193-198.
PubMed
24. Zhou XH, Zhang D, Shi J, et al.:Comparison of vitrification and conventional slow freezing for cryopreservation of ovarian tissue with respect to the number of intact primordial follicles:A meta-analysis. Medicine. 2016;95:e4095.
 
25. Shi Q, Xie Y, Wang Y, et al.:Vitrification versus slow freezing for human ovarian tissue cryopreservation:a systematic review and meta-anlaysis. Sci Rep. 2017;7:8538.
PubMed
26. Gook DA, Edgar DH, Stern C:Effect of cooling rate and dehydration regimen on the histological appearance of human ovarian cortex following cryopreservation in 1,2-propanediol. Hum Reprod. 1999;14:2061-2068.
PubMed
27. Schmidt KLT, Byskov AG, Nyboe Andersen A, et al.:Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum Reprod. 2003;18:1158-1164.
PubMed
28. Nakamura Y, Obata R, Okuyama N, et al.:Residual ethylene glycol and dimethyl sulphoxide concentration in human ovarian tissue during warming/thawing steps following cryopreservation. Reprod Biomed Online. 2017;35:311-313.
PubMed

第2章 卵巣組織の採取と移植

P.120 掲載の参考文献
1. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
2. Baird DT, Webb R, Campbell BK, et al.:Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196℃ . Endocrinology, 1999;140:462-471.
 
3. Lotz L, Dittrich R, Hoffmann I, et al.:Ovarian Tissue Transplantation:Experience From Germany and Worldwide Efficacy. Clin Med Insights Reprod Health. 2019;13:1179558119867357.
PubMed
4. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017. 377:1657-1665.
PubMed
5. Gellert SE, Pors SE, Kristensen SG, et al.:Transplantation of frozen-thawed ovarian tissue:an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018. 35:561-570.
PubMed
6. Dolmans MM, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril, 2013. 99:1514-1522.
PubMed
7. Salooja N, Shoham Z, Dalle JH:Endocrine Disorders, Fertility and Sexual Health. In The EBMT Handbook:Hematopoietic Stem Cell Transplantation and Cellular Therapies 7th ed. Springer;2019, pp. 421-427.
 
8. McLaughlin M, Albertini DF, Wallace WHB, et al.:Metaphase II oocytes from human unilaminar follicles grown in a multi-step culture system. Mol Hum Reprod. 2018;24:135-142.
 
9. Laronda MM:Engineering a bioprosthetic ovary for fertility and hormone restoration. Theriogenology. 2020;150:8-14.
PubMed
10. Wallace WH, Smith AG, Kelsey TW, et al.:Fertility preservation for girls and young women with cancer:population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15:1129-1136.
 
11. 上嶋佳織, 高江正道, 鈴木由妃, 白石絵莉子ほか:当院における小児・思春期世代女性がん患者に対する妊孕性温存の診療の取り組み. 関東連合産科婦人科学会誌. 2019;56:151-156.
 
12. Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics. Pediatrics. 1995;95:314-317.
 
P.129 掲載の参考文献
1. Roness H, Meirow D:FERTILITY PRESERVATION:Follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158:F35-F44.
PubMed
2. Beckmann MW, Lotz L, Toth B, et al.:Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation. Geburtshilfe Frauenheilkd. 2019;79:53-62.
PubMed
3. Rowell EE, Corkum KS, Lautz TB, et al.:Laparoscopic unilateral oophorectomy for ovarian tissue cryopreservation in children. J Pediatr Surg. 2019;54:543-549.
 
4. Von Wolff M, Germeyer A, Liebenthron J, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II:fertility preservation techniques. Arch Gynecol Obstet. 2018;297:257-267.
PubMed
5. Imbert R, Moffa F, Tsepelidis S, et al.:Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility:a 12-year retrospective analysis. Hum Reprod. 2014;29:1931-1940.
PubMed
P.137 掲載の参考文献
1. Wallace WH, Kelsey TW, Anderson RA:Fertility preservation in pre-pubertal girls with cancer:the role of ovarian tissue cryopreservation. Fertil Steril. 2016;105:6-12.
PubMed
2. Armenian SH, Landier W, Hudson MM, et al.:Children's Oncology Group's 2013 blueprint for research:survivorship and outcomes. Pediatr Blood Cancer. 2013;60:1063-1068.
 
3. Skinner R, Wallace WH, Levitt GA, Group UKCsCSGLE:Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol. 2006;7:489-498.
PubMed
4. Green DM, Kawashima T, Stovall M, et al.:Fertility of female survivors of childhood cancer:a report from the childhood cancer survivor study. J Clin Oncol. 2009;27:2677-2685.
PubMed
5. Raciborska A, Bilska K, Filipp E, et al.:Ovarian function in female survivors after multimodal Ewing sarcoma therapy. Pediatr Blood Cancer. 2015;62:341-345.
PubMed
6. Fallat ME, Hutter J, American Academy of Pediatrics Committee on on Bioethics, et al.:Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics. 2008;121:e1461-1469.
 
7. Preservation EGGoFF, Anderson RA, Amant F, et al.:ESHRE guideline:female fertility preservation. Hum Reprod Open. 2020;2020:hoaa052.
PubMed
8. Loren AW, Mangu PB, Beck LN, et al.:Fertility preservation for patients with cancer:American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500-2510.
 
9. Practice Committee of the American Society for Reproductive Medicine:Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy:a committee opinion. Fertil Steril. 2013;100:1214-1223.
 
10. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
11. Demeestere I, Simon P, Dedeken L, et al.:Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod. 2015;30:2107-2109.
PubMed
12. CNN health:(https://edition.cnn.com/2016/12/15/health/first-birth-from-frozenovarian-tissue/index.html)
 
13. Corkum KS, Laronda MM, Rowell EE:A review of reported surgical techniques in fertility preservation for prepubertal and adolescent females facing a fertility threatening diagnosis or treatment. Am J Surg. 2017;214:695-700.
PubMed
14. Informed consent, parental permission, and assent in pediatric practice. Committee on Bioethics, American Academy of Pediatrics. Pediatrics. 1995;95:314-317.
 
15. 木村文則:小児がん患者に対する妊孕性温存療法. ヘルスケアプロバイダのためのがん・生殖医療. メディカ出版, 2019, pp. 142-147.
 
16. ヘルシンキ宣言 人間を対象とする医学研究の倫理的原則(日本医師会訳):(http://dl.med.or.jp/dl-med/wma/helsinki2013j.pdf)
 
17. 医薬品医療機器総合機構:小児集団における医薬品の臨床試験に関するガイダンスについて (https://www.pmda.go.jp/files/000156072.pdf)
 
18. 厚生労働省医薬局審査管理課:小児集団における医薬品の臨床試験に関するガイダンスに関する質疑応答集(Q&A)について:(https://www.piis.pref.mie.lg.jp/dat/pdf/10000232_001.pdf)
 
19. 文部科学省・厚生労働省:人を対象とする医学系研究に関する倫理指針:(https://www.lifescience.mext.go.jp/files/pdf/n1443_01.pdf)
 
20. Rowell EE, Corkum KS, Lautz TB, et al.:Laparoscopic unilateral oophorectomy for ovarian tissue cryopreservation in children. J Pediatr Surg. 2019;54:543-549.
 
21. Woodruff TK:The emergence of a new interdiscipline:oncofertility. Cancer Treat Res. 2007;138:3-11.
PubMed
22. Wallace WH, Smith AG, Kelsey TW, et al.:Fertility preservation for girls and young women with cancer:population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15:1129-1136.
 
23. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
24. Shi Q, Xie Y, Wang Y, et al.:Vitrification versus slow freezing for human ovarian tissue cryopreservation:a systematic review and meta-anlaysis. Sci Rep. 2017;7:8538.
PubMed
25. Kasei R, Morimune A, Kimura F, et al.:Ovarian cryopreservation for children aged 3years or younger:A report of three cases. J Obstet Gynaecol Res. 2020;46:2164-2168.
PubMed
26. Suzuki N, Yoshioka N, Takae S, et al.:Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30:608-615.
PubMed
27. Isachenko V, Todorov P, Isachenko E, et al.:Cryopreservation and xenografting of human ovarian fragments:medulla decreases the phosphatidylserine translocation rate. Reprod Biol Endocrinol. 2016;14:79.
PubMed
28. Forabosco A, Sforza C, De Pol A, et al.:Morphometric study of the human neonatal ovary. Anat Rec. 1991;231:201-208.
PubMed
29. CNN health:(https://edition.cnn.com/2016/12/15/health/first-birth-from-frozenovarian-tissue/index.html)
 
30. Ernst E, Kjaersgaard M, Birkebaek NH, et al.:Case report:stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 2013;49:911-914.
 
31. Pacheco F, Oktay K:Current success and efficiency of autologous ovarian transplantation:A meta-analysis. Reprod Sci. 2017;24:1111-1120.
PubMed
32. Silber S, Kagawa N, Kuwayama M, et al.:Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94:2191-2196.
PubMed
P.147 掲載の参考文献
1. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
2. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
3. Dolmans MM, Falcone T, Patrizio P:Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. Fertil Steril. 2020;114:279-280.
PubMed
4. Practice Committee of the American Society for Reproductive Medicine:Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy:a committee opinion. Fertil Steril. 2019;112:1022-1033.
 
5. ESHRE Guideline Group on Female Fertility Preservation:ESHRE guideline:female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
 
6. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
7. Lambertini M, Peccatori FA, Demeestere I, et al.:Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients:ESMO Clinical Practice Guidelines. Ann Oncol. 2020;31:1664-1678.
PubMed
8. Suzuki N:Clinical Practice Guidelines for Fertility Preservation in Pediatric, Adolescent, and Young Adults with Cancer. Int J Clin Oncol. 2019;24:20-27.
 
9. ESHRE Working Group on Oocyte Cryopreservation in Europe:Oocyte and ovarian tissue cryopreservation in European countries:statutory background, practice, storage and use. Hum Reprod Open. 2017;2017:hox003.
 
10. Blumenfeld Z:Ovarian tissue transplantation and leukemia. Fertil Steril. 2018 109:69-70.
PubMed
11. Hoekman EJ, Louwe LA, Rooijers M, et al.:Ovarian tissue cryopreservation:Low usage rates and high live-birth rate after transplantation. Acta Obstet Gynecol Scand. 2020 99:213-221.
PubMed
12. Gellert SE, Pors SE, Kristensen SG, et al.:Transplantation of frozen-thawed ovarian tissue:an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018;35:561-570.
PubMed
13. Armstrong AG, Kimler BF, Smith BM, et al.:Ovarian tissue cryopreservation in young females through the Oncofertility Consortium's National Physicians Cooperative. Future oncology. Future Oncol. 2018;14(4):363-378.
 
14. Sanada Y, Harada M, Kunitomi C, et al.:A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. J Obstet Gynaecol Res. 2019;45(10):2021-2028.
PubMed
15. von Wolff M, Andersen CY, Woodruff TK, et al.:FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences? Clin Med Insights Reprod Health. 2019;13:1179558119845865.
PubMed
16. 日本産科婦人科学会HP:施設一覧. 専攻医指導施設, 各登録業務への参加状況, * ARTの登録(http://www.jsog.or.jp/facility_program/search_result_facility.php)
 
17. Beckmann MW, Lotz L, Toth B, et al.:Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation. Geburtshilfe Frauenheilkd. 2019;79:53-62.
PubMed
18. Poirot C, Abirached F, Prades M, et al.:Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 2012;379:588.
PubMed
19. Andersen CY, Kristensen SG:Novel use of the ovarian follicular pool to postpone menopause and delay osteoporosis. Reproductive biomedicine online. 2015;31:128-131.
PubMed
20. Anderson RA, Fauser B:Ovarian tissue transplantation for hormone replacement. Reprod Biomed Online. 2018;37:251-252.
PubMed
21. von Wolff M, Stute P, Fluck C:Autologous transplantation of cryopreserved ovarian tissue to induce puberty-the endocrinologists' view. Eur J Pediatr. 2016;175:2007-2010.
PubMed
22. Donnez J, Dolmans MM:Natural hormone replacement therapy with a functioning ovary after the menopause:dream or reality? Reprod Biomed Online. 2018;37:359-366.
PubMed
23. von Wolff M, Stute P, Fluck C:Autologous transplantation of cryopreserved ovarian tissue to induce puberty-the endocrinologists' view. Eur J Pediatr. 2016;175:2007-2010.
PubMed
24. Jensen AK, Kristensen SG, Macklon KT, et al.:Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark. Hum Reprod. 2015;30:2838-2345.
PubMed
25. Poirot C, Brugieres L, Yakouben K, et al.:Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center. Acta Obstet Gynecol Scand. 2019;98:630-637.
 
26. Pacheco F, Oktay K:Current Success and Efficiency of Autologous Ovarian Transplantation:A Meta-Analysis. Reprod Sci. 2017;24:1111-1120.
PubMed
27. Lotz L, Dittrich R, Hoffmann I, et al.:Ovarian Tissue Transplantation:Experience From Germany and Worldwide Efficacy. Clin Med Insights Reprod Health. 2019;13:1179558119867357.
PubMed
28. Shapira M, Dolmans MM, Silber S, et al.:Evaluation of ovarian tissue transplantation:results from three clinical centers. Fertil Steril. 2020;114:388-397.
PubMed
29. Van der Ven H, Liebenthron J, Beckmann M, et al.:Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network:tissue activity, pregnancy and delivery rates. Hum Reprod. 2016;31:2031-2041.
 
30. Demeestere I, Simon P, Dedeken L, et al.:Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod. 2015 Sep;30:2107-2109.
PubMed
31. Donnez J, Dolmans MM:Ovarian cortex transplantation:60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet. 2015;32:1167-1170.
PubMed
32. Andersen ST, Pors SE, Poulsen LC, et al.:Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue:a systematic review. Fertil Steril. 2019;112:908-921.
 
33. Dueholm Hjorth IM, Kristensen SG, Dueholm M, et al.:Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue. Fertil Steril. 2020;11:379-387.
 
34. Jensen AK, Macklon KT, Fedder J, et al.:86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue:focus on birth and perinatal outcome in 40 of these children. J Assist Reprod Genet. 2017;34:325-336.
 
35. Dolmans MM, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99:1514-1522.
PubMed
36. von Wolff M, Germeyer A, Liebenthron J, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II:fertility preservation techniques. Arch Gynecol Obstet. 2018;297:257-267.
PubMed
37. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
38. Oktay K, Harvey BE, Partridge AH, et al.:Fertility Preservation in Patients With Cancer:ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018;36:1994-2001.
PubMed
39. Balduzzi A, Dalle JH, Jahnukainen K, et al.:Fertility preservation issues in pediatric hematopoietic stem cell transplantation:practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group. Bone Marrow Transplant. 2017;52:1406-1415.
 
40. Shapira M, Raanani H, Barshack I, et al.:First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109:48-53.
 
41. Masciangelo R, Bosisio C, Donnez J, et al.:Safety of ovarian tissue transplantation in patients with borderline ovarian tumors. Hum Reprod. 2018;33:212-219.
PubMed
42. Takae S, Suzuki N:Current state and future possibilities of ovarian tissue transplantation. Reprod Med Biol. 2019;18:217-224.
PubMed
43. Beckmann MW, Dittrich R, Lotz L, et al.:Fertility protection:complications of surgery and results of removal and transplantation of ovarian tissue. Reprod Biomed Online. 2018;36:188-196.
PubMed
44. Ladanyi C, Mor A, Christianson MS, et al.:Recent advances in the field of ovarian tissue cryopreservation and opportunities for research. J Assist Reprod Genet. 2017;34:709-722.
 
44. Beckmann MW, Dittrich R, Lotz L, et al.:Operative techniques and complications of extraction and transplantation of ovarian tissue:the Erlangen experience. Arch Gynecol Obstet. 2017;295:1033-1039.
PubMed
45. Nisolle M, Casanas-Roux F, Qu J, et al.:Histologic and ultrastructural evaluation of fresh and frozen-thawed human ovarian xenografts in nude mice. Fertil Steril. 2000;74:122-129.
PubMed
46. Roness H, Meirow D:FERTILITY PRESERVATION:Follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158:F35-F44.
PubMed
47. Gavish Z, Spector I, Peer G, et al.:Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation. J Assist Reprod Genet. 2018;35:61-69.
PubMed
P.156 掲載の参考文献
1. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
2. Hossay C, Donnez J, Dolmans MM:Whole ovary cryopreservation and transplantation:A systematic review of challenges and research developments in animal experiments and humans. J Clin Med. 2020;9:3196.
PubMed
3. Donnez J, Dolmans MM:Fertility Preservation in Women. N Engl J Med. 2017;377:1657-1665.
PubMed
4. Donnez J, Dolmans MM, Pellicer A, et al.:Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue:a review of 60 cases of reimplantation. Fertil Steril. 2013;99:1503-1513.
 
5. von Wolff M, Germeyer A, Liebenthron J, et al.:Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II:fertility preservation techniques. Arch Gynecol Obstet. 2018;297:257-267.
PubMed
6. Practice Committee of the American Society for Reproductive Medicine:Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy:a committee opinion. Fertil Steril. 2019;112:1022-1033.
 

第3章 卵巣組織の凍結・移植に関する諸問題

P.163 掲載の参考文献
1. Hoffman BL, et al.:Williams Gynecology. McGraw Hill Professional:New York, USA, 2016.
 
2. 片渕秀隆, 大竹秀幸, 岡村 均. 新女性医学大系 第1巻 性器の発生・形態・機能. 卵巣の解剖・組織学と生理機能. 東京, 2001.
 
3. 日本生殖医学会. 早発卵巣不全の診断・治療. 生殖医療の必修知識. 東京, 2014, pp. 183-186.
 
4. 谷内麻子. わかりやすい早発卵巣不全のホルモン療法とその管理. 日本女性医学学会雑誌. 2016;23:301-304.
 
5. 河村和弘. 早発閉経. 臨床婦人科産科. 2016;70:1137-1142.
 
6. 都築知代, 水谷栄太, 森由紀子ほか. AMH分泌値から見たPremature ovarian failure の妊娠例の検討. 日本受精着床学会雑誌. 2016;33:1-5.
Medical*Online
7. Jeruss JS, Woodruff TK:Preservation of fertility in patients with cancer. N Engl J Med. 2009;360:902-911.
PubMed
8. Donnez J, Dolmans MM:Fertility preservation in women. Nat Rev Endocrinol. 2013;9:735-749.
PubMed
9. De Vos M, Smitz J, Woodruff TK:Fertility preservation in women with cancer. Lancet. 2014;384:1302-1310.
PubMed
10. Brevini TAL:Gametogenesis, Early Embryo Development and Stem Cell Derivation. Springer:New York, 2013.
 
11. Piprek RP(ed. ):Molecular Mechanisms of Cell Differentiation in Gonad Development. Springer:New York, 2016.
 
12. Wallace WH, Kelsey TW:Human ovarian reserve from conception to the menopause. PLoS One. 2010;5:e8772.
 
13. Boron WF, Boulpaep EL:Medical Physiology:A Cellular and Molecular Approach. 2nd ed. Elsevier Health Sciences:New York, 2012.
 
14. Cossigny DA, Findlay JK, Drummond AE:The effects of FSH and activin A on follicle development in vitro. Reproduction. 2012;143:221-229.
PubMed
15. McGee EA, Hsueh AJ:Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21:200-214.
PubMed
16. Ben-Aharon I, Meizner I, Granot T, et al.:Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity. Oncologist. 2012;17:1386-1393.
PubMed
17. Meirow D, Dor J, Kaufman B, et al.:Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod. 2007;22:1626-1633.
PubMed
18. Lambertini M, Horicks F, Del Mastro L, et al.:Ovarian protection with gonadotropinreleasing hormone agonists during chemotherapy in cancer patients:From biological evidence to clinical application. Cancer Treat Rev. 2019;72:65-77.
PubMed
19. Poggio F, Lambertini M, Bighin C, et al.:Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients:A Review. Clin Med Insights Reprod Health. 2019;13:1179558119864584.
PubMed
20. Meeker JD, Benedict MD:Infertility, Pregnancy Loss and Adverse Birth Outcomes in Relation to Maternal Secondhand Tobacco Smoke Exposure. Curr Womens Health Rev. 2013;9:41-49.
PubMed
21. Meirow D, Biederman H, Anderson RA, et al.:Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53:727-739.
PubMed
22. Keating AF, Sen N, Sipes IG, et al.:Dual protective role for glutathione S-transferase class pi against VCD-induced ovotoxicity in the rat ovary. Toxicol Appl Pharmacol. 2010;247:71-75.
PubMed
23. Nam EY, Kim SA, Kim H, et al.:Akt activation by Evodiae Fructus extract protects ovary against 4-vinylcyclohexene diepoxide-induced ovotoxicity. J Ethnopharmacol. 2016;194:733-739.
PubMed
24. Sonmezer M, Oktay K:Fertility preservation in female patients. Human Reproduction Update. 2004;10:251-266.
PubMed
25. Wallace WH, Thomson AB, Kelsey TW:The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117-121.
PubMed
26. Wallace WH, Anderson RA, Irvine DS:Fertility preservation for young patients with cancer:who is at risk and what can be offered? Lancet Oncol. 2005;6:209-218.
PubMed
27. Chemaitilly W, Mertens AC, Mitby P, et al.:Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91:1723-1728.
PubMed
28. Green DM, Kawashima T, Stovall M, et al.:Fertility of female survivors of childhood cancer:a report from the childhood cancer survivor study. J Clin Oncol. 2009;27:2677-2685.
PubMed
29. Sklar CA, Mertens AC, Mitby P, et al.:Premature menopause in survivors of childhood cancer:a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98:890-896.
PubMed
30. The WT, Stern C, Chander S, et al.:The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int. 2014;2014:482968.
 
31. Larsen EC, Schmiegelow K, Rechnitzer C, et al.:Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand. 2004;83:96-102.
 
32. Salooja N, Szydlo RM, Socie G, et al.Late Effects Working Party of the European Group for Blood and Marrow Transplantation:Pregnancy outcomes after peripheral blood or bone marrow transplantation:a retrospective survey. Lancet. 2001;358:271-276.
PubMed
33. Roness H, Gavish Z, Cohen Y, et al.:Ovarian follicle burnout:a universal phenomenon? Cell Cycle. 2013;12:3245-3246.
PubMed
34. Blumenfeld Z:How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist. 2007;12:1044-1054.
PubMed
35. Lambertini M, Ceppi M, Poggio F, et al.:Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients:a meta-analysis of randomized studies. Ann Oncol. 2015;26:2408-2419.
PubMed
36. Munhoz RR, Pereira AA, Sasse AD, et al.:Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer:A Systematic Review and Meta-analysis. JAMA Oncol. 2016;2:65-73.
PubMed
37. Turner NH, Partridge A, Sanna G, et al.:Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients:the benefit remains uncertain. Ann Oncol. 2013;24:2224-2235.
 
38. Ayuandari S, Winkler-Crepaz K, Paulitsch M, et al.:Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice:dynamics and molecular aspects. J Assist Reprod Genet. 2016;33:1585-1593.
PubMed
39. Gavish Z, Peer G, Roness H, et al.:Follicle activation and 'burn-out' contribute to post-transplantation follicle loss in ovarian tissue grafts:the effect of graft thickness. Hum Reprod. 2014;29:989-996.
PubMed
P.173 掲載の参考文献
1. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
2. Gellert SE, Pors SE, Kristensen SG, et al.:Transplantation of frozen-thawed ovarian tissue:an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. J Assist Reprod Genet. 2018;35:561-570.
PubMed
3. Dolmans MM, Masciangelo R:Risk of transplanting malignant cells in cryopreserved ovarian tissue. Minerva Ginecologica. 2018;70:436-443
 
4. Kyono K, Doshida M, Toya M, et al.:Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. Fertil Steril. 2010;93:2429-2430.
PubMed
5. Slasky BS, Straub WH, Deutsch M:Acute lymphocytic leukemia of the ovary:the value of sonography. J Comput Tomogr. 1982;6:161-165.
PubMed
6. Meirow D. Ra'anani H, Shapira M, et al.:Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril. 2016;106:467-474.
PubMed
7. Shapira M, Raanani H, Barshack I, et al.:First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109:48-53.
 
8. Soares M, Saussoy P, Sahrari K, et al.:Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model? J Assist Reprod Genet. 2015;32:597-606.
 
9. Soares M, Saussoy P, Maskens M, et al.:Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients. Br J Haematol. 2017;178:231-239.
PubMed
10. Meirow D, Hardan I, Dor J, et al.:Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23:1007-1013.
PubMed
11. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
12. Rosendahl M, Andersen MT, Ralfkier E, et al.:Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril. 2010;94:2186-2190.
 
13. Greve T, Clasen-Linde E, Andersen MT, et al.:Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120:4311-4316.
PubMed
14. Shaw JM, Bowles J, Koopman P, et al.:Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996;11:1668-1673.
PubMed
15. Bittinger SE, Nazaretian SP, Gook DA, et al.:Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril. 2011;95:803. e3-6.
 
16. Kim SS, Radford J, Harris M, et al.:Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod. 2001;16:2056-2060.
PubMed
17. Seshadri T, Gook D, Lade S, et al.:Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer. 2006;94:1007-1010.
PubMed
18. Hoekman EJ, Smit VT, Fleming TP, et al.:Searching for metastases in ovarian tissue before autotransplantation:a tailor-made approach. Fertil Steril. 2015;103:469-477.
 
19. Meirow D, Levron J, Eldar-Geva T, et al.:Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318-321.
 
20. Dolmans MM, Jadoul P, Gilliaux S, et al.:A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013;30:305-314.
PubMed
21. Sanchez-Serrano M, Novella-Maestre E, Rosello-Sastre E, et al.:Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod. 2009;24:2238-2243.
 
22. Rosendahl M, Timmermans Wielenga V, Nedergaard L, et al.:Cryopreservation of ovarian tissue for fertility preservation:no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril. 2011;95:2158-2161.
PubMed
23. Luyckx V, Durant JF, Camboni A, et al.:Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study. J Assist Reprod Genet. 2013;30:1289-1299.
 
24. Abir R, Feinmesser M, Yaniv I, et al.:Occasional involvement of the ovary in Ewing sarcoma. Hum Reprod. 2010;25:1708-1712.
PubMed
25. Greve T, Wielenga VT, Grauslund M, et al.:Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Eur J Cancer. 2013;49:1932-1938.
PubMed
26. Dolmans MM, Iwahara Y, Donnez J, et al.:Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients. Hum Reprod. 2016;31:2292-2302.
PubMed
27. Andersen CY, Silber SJ, Bergholdt SH, et al.:Long-term duration of function of ovarian tissue transplants:case reports. Reprod Biomed Online. 2012;25:128-132.
PubMed
28. Ernst E, Kjersgaard M, Birkebek NH, et al.:Case report:stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 2013;49:911-914.
 
29. Fajau-Prevot C, Le Gac YT, Chevreau C, et al.:Ovarian Mucinous Cystadenoma After Ovarian Graft. Obstet Gynecol. 2017;129:1035-1036.
PubMed
30. Dolmans MM, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99:1514-1522.
PubMed
31. Azem F, Hasson J, Ben-Yosef D, et al.:Histologic evaluation of fresh human ovarian tissue before cryopreservation. Int J Gynecol Pathol. 2010;29:19-23.
 
32. Kim SS, Lee WS, Chung MK, et al.:Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue:8-year experience in cancer patients. Fertil Steril. 2009;91:2349-2354.
PubMed
33. Kim SS:Assessment of long term endocrine function after transplantation of frozenthawed human ovarian tissue to the heterotopic site:10 year longitudinal follow-up study. J Assist Reprod Genet. 2012;29:489-493.
 
34. Schmidt KT, Rosendahl M, Ernst E, et al.:Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure:the Danish experience. Fertil Steril. 2011;95:695-701.
PubMed
35. Dolmans MM, Jadoul P, Gilliaux S, et al.:A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013;30:305-314.
PubMed
36. Ruan X, Cheng J, Korell M, et al.:Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency:first 10 cases in China. Climacteric. 2020;23:574-580.
 
37. Kinjyo Y, Kudaka W, Ooyama T, et al.:Ovarian preservation in young women with endometrial cancer of endometrioid histology. Acta Obstet Gynecol Scand. 2015;94:430-434.
PubMed
38. Aebi S, Castiglione M;ESMO Guidelines Working Group:Epithelial ovarian carcinoma:ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19 Suppl 2:ii14-16.
 
39. Stern CJ, Gook D, Hale LG, et al.:First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Hum Reprod. 2013;28:2996-2999.
 
40. Stern CJ, Gook D, Hale LG, et al.:Delivery of twins following heterotopic grafting of frozen-thawed ovarian tissue. Hum Reprod. 2014;29:1828.
PubMed
41. Kristensen SG, Giorgione V, Humaidan P, et al.:Fertility preservation and refreezing of transplanted ovarian tissue-a potential new way of managing patients with low risk of malignant cell recurrence. Fertil Steril. 2017;107:1206-1213.
 
42. Dittrich R, Hackl J, Lotz L, et al.:Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103:462-468.
 
43. Lotz L, Montag M, van der Ven H, et al.:Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice--no evidence of malignant cell contamination. Fertil Steril. 2011;95:2612-2614. e1.
 
44. Masciangelo R, Bosisio C, Donnez J, et al.:Safety of ovarian tissue transplantation in patients with borderline ovarian tumors. Hum Reprod. 2018;33:212-219.
PubMed
45. McCarville MB, Hill DA, Miller BE, et al.:Secondary ovarian neoplasms in children:imaging features with histopathologic correlation. Pediatr Radiol. 2001;31:358-364.
PubMed
46. Oktay K, Kan MT, Rosenwaks Z:Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol. 2001;13:263-268.
PubMed
47. Greze V, Brugnon F, Chambon F, et al.:Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration. Pediatr Blood Cancer. 2017;64(5).
PubMed
48. Sonmezer M, Oktay K:Fertility preservation in female patients. Hum Reprod Update. 2004;10:251-266.
PubMed

第4章 卵巣組織の凍結の将来

P.184 掲載の参考文献
1. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet Lond Engl. 2004;364:1405-1410.
 
2. Donnez J, Manavella DD, Dolmans M-M:Techniques for ovarian tissue transplantation and results. Minerva Ginecol. 2018;70:424-431.
PubMed
3. Dittrich R, Hackl J, Lotz L, et al.:Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil Steril. 2015;103:462-468.
 
4. Donnez J, Dolmans M-M:Ovarian cortex transplantation:60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet. 2015;32:1167-1170.
PubMed
5. Jensen AK, Kristensen SG, Macklon KT, et al.:Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark. Hum Reprod. 2015;30:2838-2845.
PubMed
6. Pacheco F, Oktay K:Current Success and Efficiency of Autologous Ovarian Transplantation:A Meta-Analysis. Reprod Sci Thousand Oaks Calif. 2017;24:1111-1120.
 
7. Van der Ven H, Liebenthron J, Beckmann M, et al.:Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network:tissue activity, pregnancy and delivery rates. Hum Reprod. 2016;31:2031-2041.
 
8. von Wolff M, Dittrich R, Liebenthron J, et al.:Fertility-preservation counselling and treatment for medical reasons:data from a multinational network of over 5000 women. Reprod Biomed Online. 2015;31:605-612.
PubMed
9. Cakmak H, Katz A, Cedars MI, et al.:Effective method for emergency fertility preservation:random-start controlled ovarian stimulation. Fertil Steril. 2013;100:1673-1680.
PubMed
10. Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013;110:17474-17479.
PubMed
11. Suzuki N, Yoshioka N, Takae S, et al.:Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod Oxf Engl. 2015;30:608-615.
 
12. Silber SJ, DeRosa M, Goldsmith S, et al.:Cryopreservation and transplantation of ovarian tissue:results from one center in the USA. J Assist Reprod Genet. 2018;35:2205-2213.
PubMed
13. Keros V, Xella S, Hultenby K, et al.:Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod Oxf Engl. 2009;24:1670-1683.
 
14. Suzuki N, Hashimoto S, Igarashi S, et al. Assessment of long-term function of heterotopic transplants of vitrified ovarian tissue in cynomolgus monkeys. Hum Reprod Oxf Engl. 2012;27:2420-2429.
 
15. Liebenthron J, Montag M, Reinsberg J, et al.:Overnight ovarian tissue transportation for centralized cryobanking:a feasible option. Reprod Biomed Online. 2019;38:740-749.
PubMed
16. Kyono K, Hashimoto T, Toya M, et al.:A transportation network for human ovarian tissue is indispensable to success for fertility preservation. J Assist Reprod Genet. 2017;34:1469-1474.
 
17. Andersen CY, Rosendahl M, Byskov AG, et al.:Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod Oxf Engl. 2008;23:2266-2272.
 
18. Dittrich R, Lotz L, Keck G, et al.:Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97:387-390.
PubMed
19. Beckmann M, Lotz L, Toth B, et al.:Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation. Geburtshilfe Frauenheilkd. 2019;79:53-62.
PubMed
20. Isachenko E, Isachenko V, Nawroth F, et al.:Effect of long-term exposure at supraze ro temperatures on activity and viability of human ovarian cortex. Fertil Steril. 2009;91(4 Suppl):1556-1559.
 
21. Hicks M, Hing A, Gao L, et al.:Organ preservation. Methods Mol Biol Clifton NJ. 2006;333:331-374.
 
22. Schmidt KLT, Ernst E, Byskov AG, et al.:Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. Hum Reprod Oxf Engl. 2003;18:2654-2659.
 
23. Raffel N, Dittrich R, Orlowski P, et al.:Is Ovarian Tissue Transport at Supra-zero Temperatures Compared to Body Temperature Optimal for Follicle Survival? In Vivo. 2020;34:533-541.
PubMed
24. Kamoshita K, Okamoto N, Nakajima M, et al.:Investigation of in vitro parameters and fertility of mouse ovary after storage at an optimal temperature and duration for transportation. Hum Reprod. 2016;31:774-781.
PubMed
25. Henry L, Fransolet M, Labied S, et al.:Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. J Ovarian Res. 2016;9:4.
PubMed
P.190 掲載の参考文献
1. Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy:a committee opinion. Fertil Steril. 2019;112:1022-1033.
 
2. Anderson RA, Wallace WHB, Telfer EE. Ovarian tissue cryopreservation for fertility preservation:clinical and research perspectives. Hum Reprod Open. 2017;1:hox001.
PubMed
3. Woodruff TK. Lessons from bioengineering the ovarian follicle:a personal perspective. Reproduction. 2019;158:F113-F126.
PubMed
4. Telfer EE. FERTILITY PRESERVATION:Progress and prospects for developing human immature oocytes in vitro. Reproduction. 2019;158:F45-F54.
PubMed
5. Reddy P, Liu L, Adhikari D, et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Scinece. 2008;319:611-613.
 
6. Grosbois J, Devos M, Demeestere I. Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation. Endocr Rev. 2020;41:bnaa020.
PubMed
7. Maidarti M, Clarkson YL, McLaughlin M, et al. Inhibition of PTEN activates bovine nongrowing follicles in vitro but increases DNA damage and reduces DNA repair response. Hum Reprod. 2019;34:297-307.
PubMed
8. Hsueh AJW, Kawamura K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril. 2020;114:458-464.
PubMed
9. McLaughlin M, Albertini DF, Wallace WHB, et al.:Metaphase II oocytes from human unilaminar follicles grown in a multi-step culture system. Mol Hum Reprod. 2018;24:135-142.
 
10. Sanfins A, Rodrigues P, Albertini DF. GDF-9 and BMP-15 direct the follicle symphony. J Assist Reprod Genet. 2018;35:1741-1750.
PubMed
11. Shirasawa H, Terada Y. In vitro maturation of human immature oocytes for fertility preservation and research material. Reprod Med Biol. 2017;16;258-267.
PubMed
12. Eppig JJ and O'Brien MJ. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod. 1996;54:197-207.
 
13. O'Brien MJ, Pendola JK, Eppig JJ. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol Reprod. 2003;68:1682-1686.
PubMed
14. Hornick JE, Duncan FE, Shea LD, et al. Isolated primate primordial follicles require a rigid physical environment to survive and grow in vitro. Hum Reprod. 2012;27:1801-1810.
PubMed
15. Laronda MM, Duncan FE, Hornick JE, et al. Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue. J Assist Reprod Genet. 2014;31:1013-1028.
 
P.196 掲載の参考文献
1. Johnson J, Canning J, Kaneko T, et al.:Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145-150.
PubMed
2. Zou K, Yuan Z, Yang Z, et al.:Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol. 2009;11:631-636.
 
3. White YA, Woods DC, Takai Y, et al.:Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012;18:413-421.
PubMed
4. Imudia AN, Wang N, Tanaka Y, et al.:Comparative gene expression profiling of adult mouse ovary-derived oogonial stem cells supports a distinct cellular identity. Fertil Steril. 2013;100:1451-1458.
PubMed
5. Seandel M, James D, Shmelkov SV, et al.:Generation of functional multipotent adult stem cells from GPR125 + germline progenitors. Nature. 2007;449:346-450.
PubMed
6. Kagawa N, Silber S, Kuwayama M:Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online. 2009;18:568-577.
PubMed
7. Telfer EE, Albertini DF:The quest for human ovarian stem cells. Nat Med. 2012;18:353-354.
PubMed
8. Clarkson YL, McLaughlin M, Waterfall M, et al.:Initial characterisation of adult human ovarian cell populations isolated by DDX4 expression and aldehyde dehydrogenase activity. Sci Rep. 2018;8:6953.
PubMed
9. Zhang H, Zheng WJ, Shen Y, et al.:Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse ovaries. Proc Natl Acad Sci U S A. 2012;109:12580-12585.
 
10. Zhang H, Panula S, Petropoulos S, et al.:Adult human and mouse ovaries lack DDX4-expressing functional oogonial stem cells. Nat Med. 2015;21:1116-1118.
PubMed
11. Zarate-Garcia L, Lane SI, Merriman JA, et al.:FACS-sorted putative oogonial stem cells from the ovary are neither DDX4-positive nor germ cells. Sci Rep. 2016;6:27991.
PubMed
12. Hayashi K, Ogushi S, Kurimoto K, et al.:Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science. 2012;338:971-975.
PubMed
13. Hikabe O, Hamazaki N, Nagamatsu G, et al.:Reconstitution in vitro of the entire cycle of the mouse female germ line. Nature. 2016;539:299-303.
PubMed
14. Irie N, Weinberger L, Tang WW, et al.:SOX17 is a critical specifier of human primordial germ cell fate. Cell. 2015;160:253-268.
PubMed
15. Sasaki K, Yokobayashi S, Nakamura T, et al.:Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells. Cell Stem Cell. 2015;17:178-194.
PubMed
16. Yamashiro C, Sasaki K, Yabuta Y, et al.:Generation of human oogonia from induced pluripotent stem cells in vitro. Science. 2018;362:356-360.
PubMed
17. Telfer EE, McLaughlin M:In Vitro Development of Ovarian Follicles. Semin Reprod Med. 2011;29:15-23.
PubMed
18. McLaughlin M, Albertini DF, Wallace WHB, et al.:Metaphase II oocytes from human unilaminar follicles grown in a multistep culture system. Mol Hum Reprod. 2018;24:135-142.
 
19. Woods DC, Tilly JL:Autologous Germline Mitochondrial Energy Transfer(AUGMENT) in Human Assisted Reproduction. Semin Reprod Med. 2015;33:410-421.
PubMed
P.204 掲載の参考文献
1. Dursun P, Dogan NU, Ayhan A. Oncofertility for gynecologic and non-gynecologic cancers:fertility sparing in young women of reproductive age. Crit Rev Oncol Hematol. 2014;92(3):258-267.
PubMed
2. 日本癌治療学会編-. 総論CQ1 挙児希望を有するがん患者に対して, どのような妊孕性に関連する情報を提供するべきか?. 小児, 思春期・若年がん患者の妊孕性温存に関する診療ガイドライン2017年版. 東京, 金原出版, 2017, pp22-24.
 
3. Balduzzi A, Dalle JH, Jahnukainen K, et al.:Fertility preservation issues in pediatric hematopoietic stem cell transplantation:practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group. Bone Marrow Transplant. 2017;52:1406-1415.
 
4. Amorim CA, Shikanov A:The artificial ovary:current status and future perspectives. Future Oncol. 2016;12:2323-2332.
PubMed
5. Shapira M, Raanani H, Barshack I, et al.:First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination. Fertil Steril. 2018;109:48-53.
 
6. Jensen AK, Kristensen SG, Macklon KT, et al.:Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark. Hum Reprod. 2015;30:2838-2845.
PubMed
7. Dolmans MM, Marinescu C, Saussoy P, et al.:Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908-2914.
PubMed
8. Abir R, Aviram A, Feinmesser M, et al.:Ovarian minimal residual disease in chronic myeloid leukaemia. Reprod Biomed Online. 2014;28:255-260.
PubMed
9. Dolmans M-M, Luyckx V, Donnez J, et al.:Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertility and Sterility. 2013;99:1514-1522.
PubMed
10. Kim SS, Donnez J, Barri P, et al.:Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet. 2012;29:465-468.
PubMed
11. Asadi-Azarbaijani B, Sheikhi M, Nurmio M, et al.:Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro. Leuk Lymphoma. 2016;57:700-707.
PubMed
12. Telfer E, Torrance C, Gosden RG:Morphological study of cultured preantral ovarian follicles of mice after transplantation under the kidney capsule. J Reprod Fertil. 1990;89:565-571.
PubMed
13. Gosden RG:Restitution of fertility in sterilized mice by transferring primordial ovarian follicles. Human Reproduction. 1990;5:117-122.
PubMed
14. Carroll J, Gosden RG:Physiology:Transplantation of frozen-thawed mouse primordial follicles. Human Reproduction. 1993;8:1163-1167.
PubMed
15. Dolmans MM, Yuan WY, Camboni A, et al.:Development of antral follicles after xenografting of isolated small human preantral follicles. Reprod Biomed Online. 2008;16:705-711.
PubMed
16. Vanacker J, Luyckx V, Dolmans MM, et al.:Transplantation of an alginate-matrigel matrix containing isolated ovarian cells:first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials. 2012;33:6079-6085.
PubMed
17. Vanacker J, Dolmans MM, Luyckx V, et al.:First transplantation of isolated murine follicles in alginate. Regen Med. 2014;9:609-619.
PubMed
18. Smith RM, Shikanov A, Kniazeva E, et al.:Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility. Tissue Eng Part A. 2014;20:3021-3030.
 
19. Kniazeva E, Hardy AN, Boukaidi SA, et al.:Primordial Follicle Transplantation within Designer Biomaterial Grafts Produce Live Births in a Mouse Infertility Model. Sci Rep. 2015;5:17709.
 
20. Chiti MC, Dolmans MM, Orellana R, et al.:Influence of follicle stage on artificial ovary outcome using fibrin as a matrix. Hum Reprod. 2015;31:427-435.
PubMed
21. Rajabzadeh AR, Eimani H, Mohseni Koochesfahani H, et al.:Morphological study of isolated ovarian preantral follicles using fibrin gel plus platelet lysate after subcutaneous transplantation. Cell J. 2015;17:145-152.
PubMed
22. Paulini F, Vilela JM, Chiti MC, et al.:Survival and growth of human preantral follicles after cryopreservation of ovarian tissue, follicle isolation and short-term xenografting. Reprod Biomed Online. 2016;33:425-432.
PubMed
23. Kim J, Perez AS, Claflin J, et al.:Synthetic hydrogel supports the function and regeneration of artificial ovarian tissue in mice. NPJ Regen Med. 2016;1:16010.
PubMed
24. Laronda MM, Rutz AL, Xiao S, et al.:A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice. Nat Commun. 2017;8:15261.
 
25. Cho E, Kim YY, Noh K, et al.:A new possibility in fertility preservation:The artificial ovary. J Tissue Eng Regen Med. 2019;13:1294-1315.
 
26. Parenteau-Bareil R, Gauvin R, Berthod F:Collagen-Based Biomaterials for Tissue Engineering Applications. Materials(Basel). 2010;3:1863-1887.
 
27. Dolmans MM, Martinez-Madrid B, Gadisseux E, et al.:Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice. Reproduction. 2007;134:253-262.
PubMed
28. Luyckx V, Dolmans MM, Vanacker J, et al.:First step in developing a 3D biodegradable fibrin scaffold for an artificial ovary. J Ovarian Res. 2013;6:83.
PubMed
29. Luyckx V, Dolmans MM, Vanacker J, et al.:A new step toward the artificial ovary:survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold. Fertil Steril. 2014101:1149-1156.
 
30. Hoesli CA, Kiang RLJ, Raghuram K, et al.:Mammalian Cell Encapsulation in Alginate Beads Using a Simple Stirred Vessel. J Vis Exp. 2017;(124):55280.
PubMed
31. Shikanov A, Xu M, Woodruff TK, et al.:A method for ovarian follicle encapsulation and culture in a proteolytically degradable 3 dimensional system. J Vis Exp. 2011;(49):2695.
 
32. Arenas-Herrera JE, Ko IK, Atala A, et al.:Decellularization for whole organ bioengineering. Biomed Mater. 2013;8:014106.
PubMed
33. Laronda MM, Jakus AE, Whelan KA, et al.:Initiation of puberty in mice following decellularized ovary transplant. Biomaterials. 2015;50:20-29.
PubMed
34. Yoon DM, Fisher JP:Natural and Synthetic Polymeric Scaffolds. In:Biomedical Materials. Narayan R(ed. ), Cham:Springer International Publishing;2021, pp. 257-283.
 
35. Thomas-Teinturier C, Salenave S:[Endocrine sequelae after treatment of pediatric cancer:From childhood to adulthood]. Bull Cancer. 2015;102:612-621.
PubMed
36. Sun F, Betzendahl I, Shen Y, et al.:Preantral follicle culture as a novel in vitro assay in reproductive toxicology testing in mammalian oocytes. Mutagenesis. 2004;19:13-25.
 
P.211 掲載の参考文献
1. Hudson MM:Reproductive outcomes for survivors of childhood cancer. Obstet. Gynecol. 2010;116:1171-1183.
PubMed
2. Thomson AB, Campbell AJ, Kelnar CJH, et al.:Semen quality and spermatozoal DNA integrity in survivors of childhood cancer:A case-control study. Lancet. 2002;360:361-367.
PubMed
3. Daudin M, Rives N, Walschaerts M, et al.:Sperm cryopreservation in adolescents and young adults with cancer:Results of the French national sperm banking network(CECOS). Fertil Steril. 2015;103:478-486. e1
 
4. Onofre J, Baert Y, Faes K, et al.:Cryopreservation of testicular tissue or testicular cell suspensions:a pivotal step in fertility preservation. Hum Reprod Update. 2016;22:744-761.
PubMed
5. Picton HM, Wyns C, Anderson RA, et al.:A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys. Hum Reprod. 2015;30:2463-2475.
 
6. Valli-Pulaski H, Peters KA, Gassei K, et al.:Testicular tissue cryopreservation:8 years of experience from a coordinated network of academic centers. Hum. Reprod. 2019;34:966-977.
PubMed
7. Goossens E, Jahnukainen K, Mitchell R, et al.:Fertility preservation in boys:recent developments and new insights. Hum Reprod Open. 2020;2020:hoaa016.
PubMed
8. Polge C, Smith AU, Parkes AS:Revival of Spermatozoa after Vitrification and Dehydration at Low Temperatures. Nature. 1949;164:666.
PubMed
9. Mazur P:Cryobiology:The freezing of biological systems. Science. 1970;168:939-949.
PubMed
10. Mazur P:The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology. 1977;14:251-272.
PubMed
11. Arkoun B, Dumont L, Milazzo JP, et al.:Does soaking temperature during controlled slow freezing of pre-pubertal mouse testes influence course of in vitro spermatogenesis? Cell Tissue Res. 2016;364:661-674.
PubMed
12. Chen C:Pregnancy After Human Oocyte Cryopreservation. Lancet. 1986;327:884-886.
 
13. Schlatt S, Kim S, Gosden R:Spermatogenesis and steroidogenesis in mouse, hamster and monkey testicular tissue after cryopreservation and heterotopic grafting to castrated hosts. Reproduction. 2002;124:339-346.
PubMed
14. Yildiz C, Mullen B, Jarvi K, et al.:Effect of different cryoprotectant agents on spermatogenesis efficiency in cryopreserved and grafted neonatal mouse testicular tissue. Cryobiology. 2013;67:70-75.
PubMed
15. Baert Y, Goossens E, Van Saen D, et al.:Orthotopic grafting of cryopreserved prepubertal testicular tissue:In search of a simple yet effective cryopreservation protocol. Fertil Steril. 2012;97:1152-1157. e1-2.
 
16. Shinohara T, Inoue K, Ogonuki N, et al.:Birth of offspring following transplantation of cryopreserved immature testicular pieces and in-vitro microinsemination. Hum Reprod. 2002;17:3039-3045.
PubMed
17. Benvenutti L, Salvador RA, Til D, et al.:Wistar rats immature testicular tissue vitrification and heterotopigrafting. J Bras Reprod Assist. 2018;22:167-173.
 
18. Kirpatovskii VI, Efremov GD, Frolova E V:Ectopic Organogenesis after Allotransplantation of Freshly Removed or Cryopreserved Neonatal Testicle under the Renal Capsule in Rats. Bull Exp Biol Med. 2018;166:268-273.
PubMed
19. Abrishami M, Anzar M, Yang Y, et al.:Cryopreservation of immature porcine testis tissue to maintain its developmental potential after xenografting into recipient mice. Theriogenology. 2010;73:86-96.
PubMed
20. Pukazhenthi BS, Nagashima J, Travis AJ, et al.:Slow freezing, but not vitrification supports complete spermatogenesis in cryopreserved, neonatal sheep testicular xenografts. PLoS One. 2015;10(4):e0123957.
 
21. Pothana L, Makala H, Devi L, et al.:Germ cell differentiation in cryopreserved, immature, Indian spotted mouse deer(Moschiola indica)testes xenografted onto mice. Theriogenology. 2015;83:625-633.
PubMed
22. Kaneko H, Kikuchi K, Men NT, et al.:Production of sperm from porcine fetal testicular tissue after cryopreservation and grafting into nude mice. Theriogenology. 2017;91:154-162.
PubMed
23. Jahnukainen K, Ehmcke J, Hergenrother SD, et al.:Effect of cold storage and cryopreservation of immature non-human primate testicular tissue on spermatogonial stem cell potential in xenografts. Hum Reprod. 2007;22:1060-1067.
PubMed
24. Jahnukainen K, Ehmcke J, Nurmio M, et al.:Autologous ectopic grafting of cryopreserved testicular tissue preserves the fertility of prepubescent monkeys that receive sterilizing cytotoxic therapy. Cancer Res. 2012;72:5174-5178.
PubMed
25. Fayomi AP, Peters K, Sukhwani M, et al.:Autologous grafting of cryopreserved prepubertal rhesus testis produces sperm and offspring. Science. 2019;363:1314-1319.
PubMed
26. Poels J, Van Langendonckt A, Dehoux JP, et al.:Vitrification of non-human primate immature testicular tissue allows maintenance of proliferating spermatogonial cells after xenografting to recipient mice. Theriogenology. 2012;77:1008-1013.
PubMed
27. Wyns C, Curaba M, Martinez-Madrid B, et al.:Spermatogonial survival after cryopreservation and short-term orthotopic immature human cryptorchid testicular tissue grafting to immunodeficient mice. Hum. Reprod. 2007;22:1603-1611.
PubMed
28. Wyns C, Van Langendonckt A, Wese FX, et al.:Long-term spermatogonial survival in cryopreserved and xenografted immature human testicular tissue. Hum. Reprod. 2008;23:2402-2414.
PubMed
29. Hutka M, Kadam P, Van Saen D, et al.:Fertility preservation in childhood cancer:Endocrine activity in prepubertal human testis xenografts exposed to a pubertal hormone environment. Cancers(Basel). 2020;12:1-21.
PubMed
30. Poels J, Abou-Ghannam G, Herman S, et al.:In Search of Better Spermatogonial Preservation by Supplementation of Cryopreserved Human Immature Testicular Tissue Xenografts with N-acetylcysteine and Testosterone. Front Surg. 2014;1:1-9.
 
31. Poels J, Van Langendonckt A, Many MC, et al.:Vitrification preserves proliferation capacity in human spermatogonia. Hum Reprod. 2013;28:578-589.
PubMed
32. Milazzo JP, Vaudreuil L, Cauliez B, et al.:Comparison of conditions for cryopreservation of testicular tissue from immature mice. Hum. Reprod. 2008;23:17-28.
PubMed
33. Dumont L, Arkoun B, Jumeau F, et al.:Assessment of the optimal vitrification protocol for pre-pubertal mice testes leading to successful in vitro production of flagellated spermatozoa. Andrology. 2015;3:611-625.
PubMed
34. Yokonishi T, Sato T, Komeya M, et al.:Offspring production with sperm grown in vitro from cryopreserved testis tissues. Nat Commun. 2014;5:4320.
PubMed
35. Travers A, Milazzo JP, Perdrix A, et al.:Assessment of freezing procedures for rat immature testicular tissue. Theriogenology. 2011;76:981-990.
PubMed
36. Saulnier J, Oblette A, Delessard M, et al.:Improving Freezing Protocols and Organotypic Culture:A Histological Study on Rat Prepubertal Testicular Tissue. Ann Biomed Eng. 2021;49:203-218.
 
37. Keros V, Rosenlund B, Hultenby K, et al.:Optimizing cryopreservation of human testicular tissue:Comparison of protocols with glycerol, propanediol and dimethylsulphoxide as cryoprotectants. Hum Reprod. 2005;20:1676-1687.
PubMed
38. Kvist K, Thorup J, Byskov AG, et al, et al.:Cryopreservation of intact testicular tissue from boys with cryptorchidism. Hum Reprod. 2006;21:484-491.
PubMed
39. Fridstro M, Keros V, Hultenby K, et al.:Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod. 2007;22:1384-1395.
 
40. Portela JMD, de Winter-Korver CM, van Daalen SKM, et al. Assessment of fresh and cryopreserved testicular tissues from(pre)pubertal boys during organ culture as a strategy for in vitro spermatogenesis. Hum Reprod. 2019;34:2443-2455.
PubMed
41. Curaba M, Poels J, Van Langendonckt A, et al.:Can prepubertal human testicular tissue be cryopreserved by vitrification? Fertil Steril. 2011;95:2123. e9-2123. e12.
 
42. Sato T, Katagiri K, Gohbara A, et al.:in vitro production of functional sperm in cultured neonatal mouse testes. Nature. 2011;471:504-507.
PubMed
43. Komeya M, Sato T, Ogawa T:In vitro spermatogenesis:A century-long research journey, still half way around. Reprod Med Biol. 2018;17:407-420.
PubMed
44. Komeya M, Kimura H, Nakamura H, et al.:Long-term ex vivo maintenance of testis tissues producing fertile sperm in a microfluidic device. Sci Rep. 2016;6:21472.
 
45. Komeya M, Hayashi K, Nakamura H, et al.:Pumpless microfluidic system driven by hydrostatic pressure induces and maintains mouse spermatogenesis in vitro. Sci Rep. 2017;7:15459.
PubMed

第5章 本邦におけるがん・生殖医療への支援

P.223 掲載の参考文献
1. 厚生労働省:がん対策推進基本計画(第1期) (https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/gan_keikaku03.pdf)
 
2. 厚生労働省:がん対策推進基本計画(第2期) (https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/gan_keikaku02.pdf)
 
3. 厚生労働省:がん対策推進基本計画 中間評価報告書(第2期) (https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000089218.pdf)
 
4. 第64回がん対策推進協議会(議事録) (https://www.mhlw.go.jp/stf/shingi2/0000153232.html)
 
5. 厚生労働省:がん対策推進基本計画(第3期) (https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000196973.pdf)
 
6. 厚生労働省委託事業:患者体験調査報告書 平成30年度調査 (https://www.ncc.go.jp/jp/cis/divisions/health_s/H30_all.pdf)
 
7. 第3 期がん対策推進基本計画中間評価指標一覧 (https://www.mhlw.go.jp/content/10901000/000540228.pdf)
 
P.230 掲載の参考文献
1. FertiPROTEKT ホームページ:(https://www.fertiprotekt.com)
 
2. Schmidt KLT, Ernst E, Byskov AG, et al.:Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. Human Reproduction. 2003;18:2654-2659.
PubMed
P.238 掲載の参考文献
1. von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network Ferti-PROTEKT. Arch Gynecol Obstet. 2011;284:427-435.
 
2. Germeyer A:Registerdaten 2015 Fertiprotekt. 2016. https://static1.squarespace.com/static/560a328fe4b0e8c4f373857e/t/57206c853c44d81ea19e790b/1461742728020/registerdaten_fertiprotekt_2015.pdf.
 
3. von Wolff M, Capp E, Jauckus J, et al. Timing of ovarian stimulation in patients prior to gonadotoxic therapy:an analysis of 684 stimulations. Eur J Obstet Gynecol Reprod Biol. 2016;199:146-149.
PubMed
4. Van der Ven H, Liebenthron J, Beckmann M, et al. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network:tissue activity, pregnancy and delivery rates. Hum Reprod 2016;31:2031-2041.
 
5. Calhaz-Jorge C, De Geyter CH, Kupka MS, et al. Survey on ART and IUI:legislation, regulation, funding and registries in European countries:The European IVF-monitoring Consortium(EIM)for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open. 2020;2020:hoz044.
PubMed
6. Anazodo AC, Gerstl B, Stern CJ, et al. Utilizing the Experience of Consumers in Consultation to Develop the Australasian Oncofertility Consortium Charter. J Adolesc Young Adult Oncol. 2016;5:232-239.
 
7. Anazodo AC, Stern CJ, McLachlan RI, et al. A Study Protocol for the Australasian Oncofertility Registry:Monitoring Referral Patterns and the Uptake, Quality, and Complications of Fertility Preservation Strategies in Australia and New Zealand. J Adolesc Young Adult Oncol. 2016;5:215-225.
PubMed
8. 高井 泰. ドイツ・スイスおよびオーストラリアにおける若年がん患者に対するがん・生殖医療の実際-わが国として学ぶべきものは? 日本がん・生殖医療学会誌. 2018;1:40-44.
 
9. Oncofertility Consortium website(https://oncofertility.northwestern.edu)
 
10. Moravek MB, Confino R, Smith KN, et al. Long-term outcomes in cancer patients who did or did not pursue fertility preservation. Fertil Steril. 2018;109:349-355.
PubMed
11. Rashedi AS, de Roo SF, Ataman LM, et al. Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe. J Glob Oncol. 2018;1-16.
 
12. Inhorn MC, Birenbaum-Carmeli D, Westphal LM, et al. Medical egg freezing:the importance of a patient-centered approach to fertility preservation. J Assist Reprod Genet. 2018;35:49-59.
PubMed
13. Kyono K, Hashimoto T, Toya M, et al. A transportation network for human ovarian tissue is indispensable to success for fertility preservation. J Assist Reprod Genet. 2017;34:1469-1474.
 
14. The ESHRE Working Group on Oocyte Cryopreservation in Europe, Shenfield F, de Mouzon J, et al. Oocyte and ovarian tissue cryopreservation in European countries:statutory background, practice, storage and use. Hum Reprod Open. 2017;hox003.
 
15. 御舩美絵, 北野敦子:がん治療後に子どもを持つ可能性を残す-思春期・若年成人がん患者に対するがん生殖医療に要する時間および経済的負担に関する実態調査. 2017. https://www.fpcr.or.jp/pdf/p11/H28mihune.pdf.
 
16. 平成28年度厚生労働省子ども・子育て支援推進調査研究事業:若年がん患者に対するがん・生殖医療(妊孕性温存治療)の有効性に関する調査研究. 2016. http://www.marianna-u.ac.jp/file/houjin/news/h28kosodatekekka.pdf.
 
17. Yumura Y, Tsujimura A, Okada H, et al. Current status of sperm banking for young cancer patients in Japanese nationwide survey. Asian J Androl. 2018;20:336-341.
PubMed
18. Sanada Y, Harada M, Kunitomi C, et al. A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. J Obstet Gynaecol Res. 2019;45:2021-2028.
PubMed
P.250 掲載の参考文献
1. 最高裁第二小法廷判決平成18年10月27日(裁判集民事221号775頁).
 
2. 最高裁第三小法廷判決平成13年11月27日(民集55巻6号1154頁).
 
3. 仙台地裁判決平成22年9月30日(医療判例解説30号132頁), 裁判所ウェブサイト:(https://www.courts.go.jp/app/files/hanrei_jp/753/080753_hanrei.pdf)
 
4. 最高裁大法廷決定平成25年9月4日(民集67巻6号1320頁).
 
5. 最高裁第三小法廷決定平成25年12月10日(民集67巻9号1847頁).
 
6. 花元 彩:性別の取扱い取り扱い変更の審判を受けた者の妻が婚姻中に懐胎した子と嫡出推定. 『新・判例解説Watch 2014年10月』(速報判例解説15号97-100頁).
 
7. 大坂晃由, 小堀善友, 新井学ほか:性同一性障害当事者に対して性別適合手術前に精子凍結保存を行った1例. 泌尿器科紀要 2018;64:451-453.
 
8. 2021年6月4日のNHK NEWS WEB, 同日の弁護士ドットコムニュース(Yahoo! JAPAN ニュース) https://www3.nhk.or.jp/news/html/20210604/k10013068041000.html https://news.yahoo.co.jp/articles/5f10f7c4e76c63330d12085a244d3e54c21be694
 
9. 最高裁第二小法廷判決平成18年9月4日(民集60巻7号2563頁).
 
10. 最高裁第三小法廷判決平成26年1月14日(民集68巻1号1頁).
 
11. 大阪高裁判決平成17年5月20日(判例時報1919号107頁).
 
12. 最高裁第二小法廷判決平成19年3月23日(民集61巻2号619頁).
 
13. 水沼直樹:医療における民法改正による影響とちょっとした工夫. 病院安全教育. 2020;6・7月号:113-117.
 
P.258 掲載の参考文献
1. 京野廣一, 中村祐介, 竹重勇哉ほか:世界情勢からみる日本の小児がんの妊孕性温存の方向性. 日本受精着床学会雑誌. 2020;37:273-279.
 
2. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
3. Dolmans MM, Jadoul P, Gilliaux S, et al.:A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet. 2013;30:305-314.
PubMed
4. Rosendahl M, Schmidt KT, Ernst E, et al.:Cryopreservation of ovarian tissue for a decade in Denmark:a view of the technique. Reprod Biomed Online. 2011;22:162-171.
 
5. Segers I, Bardhi E, mateizel I, et al.:Live births following fertility preservation using invitro maturation of ovarian tissue oocytes. Hum Reprod. 2020;35:2026-2036.
PubMed
6. Pomeroy KO:Liquid nitrogen storage tank failure:Can we improve the current system? Fertil Steril Dialog. 2018. (https://www.fertstertdialog.com/posts/33372-pomeroy-consider-this)
 
7. 京野廣一:自然災害に対する生殖補助医療施設のリスクマネージメント-東日本大震災に遭遇して. 日本卵子学会誌. 2011;28:180-189.
 
8. 日本産業・医療ガス協会:医療ガスと医療ガス設備大震災の教訓と大震災への防災対策. 2019.
 
9. 京野廣一:S1-1 生殖医療における危機管理:東日本大震災を経験して. 日本生殖医学会雑誌. 2019;64:111.
 
10. 宮崎智之:S1-2 自然災害における培養器及び周辺機器の危機管理対策. 日本生殖医学会雑誌. 2019;64:112.
 
11. 宇野澄人:S1-3 震災時におけるBCP(事業継続計画)策定. 日本生殖医学会雑誌. 2019;64:113.
 
12. 竹森現紗:S1-4 災害時の危機管理と法的責任. 日本生殖医学会雑誌. 2019;64:114(232).
 
13. Poirot C, Abirrached F, Prades M, et al.:Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 2012;379:588.
 
14. Ernst E, Kjaersgaard M, Birkebaek NH, et al.:Case report:Stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue. Eur J Cancer. 2013;49:911-914.
 
15. Demeestere I, Simon P, Dedeken L, et al.:Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod. 2015;30:2107-2109.
PubMed
16. Matthews S, Picton H, Ernst E, et al.:Successful pregnancy in a woman previously suffering from β-thalassemia following transplantation of ovarian tissue cryopreserved before puberty. Minerva Ginecol. 2018;70:432-435.
 
17. 宮地 充, 細井 創:小児がん領域における妊孕性温存治療. 京都府立医科大学雑誌. 2017;126:555-564.
 
18. 橘真紀子, 三善陽子:がん患者の妊孕性・生殖機能温存のための診療マニュアル. 金原出版, 2019, pp. 60-62.
 
19. Kyono K, Hashimoto T, Toya M, et al.:A transportation network for human ovarian tissue is indispensable to success for fertility preservation. J Assist Reprod Genet. 2017;34:1469-1474.
 
20. Kyoya T, Nakamura Y, Miyatani S, et al.:Evaluation of oxygen consumption in human vitrified and warmed pre-antral follicles after prolonged low temperatures. Reprod Med Biol. 2014;3:47-52.
 
21. Liebenthron J, Montag M, Reinsberg J, et al.:Overnight ovarian tissue transportation for centralized cryobanking:a feasible option. Reprod Biomed Online. 2019;38:740-749.
PubMed
22. Von Wolff M, Andersen CY, Woodruff TK, et al.:Ferti PROTEKT, oncofertility consortium and the Danish fertility-preservation networks - What can we learn from their experiences? Clin Med Insights Reprod Health. 2019;13:1-17.
 
23. Pacheco F, Oktay K:Current success and efficiency of autologous ovarian transplantation:a meta-analysis. Reprod Sci. 2017;24:1111-1120.
PubMed
24. Hossay C, Donnez J, Dolmans MM:Whole ovary cryopreservation and transplantation:a systemic review of challenges and research developments in animal experiments and humans. J Clin Med. 2020;9:3196.
 
25. 石川穂香, 服部裕充, 竹重勇哉ほか:生殖補助医療で使用される凍結保存タンクの清浄度. 日本受精着床学会雑誌. 2020;37:245-249.
 
26. Takeshige Y, Takahashi M, Hashimoto T, et al.:Six-year follow up of children born from vitrified oocytes. Reprod Biomed Online. 2021;S1472-6483(20)30619-2.
 

【Column】 卵巣組織凍結ならびに移植手術の "偉人たち"

P.265 掲載の参考文献
1. Gosden RG, Baird DT, Wade JC, et al.:Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod. 1994;9:597-603.
PubMed
2. Oktay K, Economos K, Kan M, et al.:Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001;286:1490-1493.
 
3. Oktay K, Kim JY, Barad D, et al.:Association of BRCA1 mutations with occult primary ovarian insufficiency:a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28:240-244.
PubMed
4. Oktay K, Moy F, Titus S, et al.:Age-related decline in DNA repair function explains diminished ovarian reserve, earlier menopause, and possible oocyte vulnerability to chemotherapy in women with BRCA mutations. J Clin Oncol. 2014;32:1093-1094.
PubMed
5. Lin W, Titus S, Moy F, et al.:Ovarian Aging in Women With BRCA Germline Mutations. J Clin Endocrinol Metab. 2017;102:3839-3847.
PubMed
6. Azim AA, Costantini-Ferrando M, Oktay K, et al.:Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer:a prospective controlled study. J Clin Oncol. 2008;26:2630-2635.
PubMed
7. Donnez J, Dolmans MM, Demylle D, et al.:Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405-1410.
PubMed
8. Donnez J, Dolmans MM, Squifflet J, et al.:Live birth after allografting of ovarian cortex between monozygotic twins with Turner syndrome(45,XO/46,XX mosaicism)and discordant ovarian function. Fertil Steril. 2011;96:1407-1411.
PubMed
9. Donnez J, Squifflet J, Pirard C, et al.:Restoration of ovarian function after allografting of ovarian cortex between genetically non-identical sisters. Hum Reprod. 2010;25:2489-2495.
PubMed
10. Donnez J, Squifflet J, Pirard C, et al.:Live birth after allografting of ovarian cortex between genetically non-identical sisters. Hum Reprod. 2011;26:1384-1388.
PubMed
11. Meirow D, Levron J, Eldar-Geva T, et al.:Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353:318-321.
 
12. Meirow D, Epstein M, Lewis H, et al.:Administration of cyclophosphamide at different stages of follicular maturation in mice:effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16:632-637.
PubMed
13. Kalich-Philosoph L, Roness H, Carmely A, et al.:Cyclophosphamide triggers follicle activation and 'burnout';AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5:185ra62.
PubMed
14. Gook DA, Edgar DH, Borg J, et al.:Diagnostic assessment of the developmental potential of human cryopreserved ovarian tissue from multiple patients using xenografting. Hum Reprod. 2005;20:72-78.
PubMed
15. Gook DA, Osborn SM, Bourne H, et al.:Fertilization of human oocytes following cryopreservation;normal karyotypes and absence of stray chromosomes. Hum Reprod. 1994;9:684-691.
PubMed
16. Gook DA, Osborn SM, Johnston WI:Cryopreservation of mouse and human oocytes using 1,2-propanediol and the configuration of the meiotic spindle. Hum Reprod. 1993;8:1101-1109.
PubMed
17. Gook DA, Osborn SM, Johnston WI:Parthenogenetic activation of human oocytes following cryopreservation using 1,2-propanediol. Hum Reprod. 1995;10:654-658.
PubMed
18. Kim SS, Hwang IT, Lee HC:Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function. Fertil Steril. 2004;82:930-932.
PubMed
19. Kim SS, Lee WS, Chung MK, et al.:Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue:8-year experience in cancer patients. Fertil Steril. 2009;91:2349-2354.
PubMed
20. Andersen CY, Rosendahl M, Byskov AG, et al.:Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23:2266-2272.
PubMed
21. Ernst E, Bergholdt S, Jorgensen JS, et al.:The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod. 2010;25:1280-1281.
PubMed
22. Morris RT:The ovarian graft. NY Med J. 1895;62:436.
 
23. Morris RT:Lectures on appendicitis and notes on other subjects. New York:G.P. Putnam's Sons;1895.
 

書評

最近チェックした商品履歴

Loading...